<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T14:48:10Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8912132" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8912132</identifier>
        <datestamp>2022-03-11</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8912132</article-id>
              <article-id pub-id-type="pmcid">PMC8912132</article-id>
              <article-id pub-id-type="pmc-uid">8912132</article-id>
              <article-id pub-id-type="pmid">35271667</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0265108</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-21-31461</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Bioenergetics</subject>
                      <subj-group>
                        <subject>Energy-Producing Organelles</subject>
                        <subj-group>
                          <subject>Mitochondria</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Cell Biology</subject>
                    <subj-group>
                      <subject>Cellular Structures and Organelles</subject>
                      <subj-group>
                        <subject>Energy-Producing Organelles</subject>
                        <subj-group>
                          <subject>Mitochondria</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Brain</subject>
                      <subj-group>
                        <subject>Hippocampus</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Brain</subject>
                      <subj-group>
                        <subject>Hippocampus</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Enzymology</subject>
                      <subj-group>
                        <subject>Enzymes</subject>
                        <subj-group>
                          <subject>Oxidoreductases</subject>
                          <subj-group>
                            <subject>Dehydrogenases</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Proteins</subject>
                      <subj-group>
                        <subject>Enzymes</subject>
                        <subj-group>
                          <subject>Oxidoreductases</subject>
                          <subj-group>
                            <subject>Dehydrogenases</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Metabolism</subject>
                      <subj-group>
                        <subject>Metabolic Pathways</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Metabolism</subject>
                      <subj-group>
                        <subject>Protein Metabolism</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Proteins</subject>
                      <subj-group>
                        <subject>Serum Proteins</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Metabolism</subject>
                      <subj-group>
                        <subject>Metabolic Processes</subject>
                        <subj-group>
                          <subject>Citric Acid Cycle</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Metabolism</subject>
                      <subj-group>
                        <subject>Energy Metabolism</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Physiological Processes</subject>
                      <subj-group>
                        <subject>Energy Metabolism</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>The mitochondrial proteomic changes of rat hippocampus induced by 28-day simulated microgravity</article-title>
                <alt-title alt-title-type="running-head">Simulated microgravity alters mitochondrial proteome</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" equal-contrib="yes">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6023-2258</contrib-id>
                  <name>
                    <surname>Ji</surname>
                    <given-names>Guohua</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Chang</surname>
                    <given-names>Hui</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Yang</surname>
                    <given-names>Mingsi</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chen</surname>
                    <given-names>Hailong</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wang</surname>
                    <given-names>Tingmei</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Liu</surname>
                    <given-names>Xu</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lv</surname>
                    <given-names>Ke</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Yinghui</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Song</surname>
                    <given-names>Bo</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Qu</surname>
                    <given-names>Lina</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, China</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Department of Pathology and Forensics, College of Basic Medical Sciences, Dalian Medical University, Dalian, China</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Chambery</surname>
                    <given-names>Angela</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Universita degli studi della Campania, ITALY</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>linaqu@263.net</email> (LQ); <email>bosong@dmu.edu.cn</email> (BS)</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>10</day>
                <month>3</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2022</year>
              </pub-date>
              <volume>17</volume>
              <issue>3</issue>
              <elocation-id>e0265108</elocation-id>
              <history>
                <date date-type="received">
                  <day>29</day>
                  <month>9</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>23</day>
                  <month>2</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2022 Ji et al</copyright-statement>
                <copyright-year>2022</copyright-year>
                <copyright-holder>Ji et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0265108.pdf"/>
              <abstract>
                <p>A large number of aerospace practices have confirmed that the aerospace microgravity environment can lead to cognitive function decline. Mitochondria are the most important energy metabolism organelles, and some studies demonstrate that the areospace microgravity environment can cause mitochondrial dysfunction. However, the relationships between cognitive function decline and mitochondrial dysfunction in the microgravity environment have not been elucidated. In this study, we simulated the microgravity environment in the Sprague-Dawley (SD) rats by -30° tail suspension for 28 days. We then investigated the changes of mitochondrial morphology and proteomics in the hippocampus. The electron microscopy results showed that the 28-day tail suspension increased the mitochondria number and size of rat hippocampal neuronal soma. Using TMT-based proteomics analysis, we identified 163 differentially expressed proteins (DEPs) between tail suspension and control samples, and among them, 128 proteins were upregulated and 35 proteins were downregulated. Functional and network analyses of the DEPs indicated that several of mitochondrial metabolic processes including the tricarboxylic acid (TCA) cycle were altered by simulating microgravity (SM). We verified 3 upregulated proteins, aconitate hydratase (ACO2), dihydrolipoamide S-succinyltransferase (DLST), and citrate synthase (CS), in the TCA cycle process by western blotting and confirmed their differential expressions between tail suspension and control samples. Taken together, our results demonstrate that 28-day tail suspension can cause changes in the morphology and metabolic function of hippocampus mitochondria, which might represent a mechanism of cognitive disorder caused by aerospace microgravity.</p>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution>The Foundation of State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center</institution>
                  </funding-source>
                  <award-id>SMFA17A03, SMFA19B02, SMFA19K08</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6023-2258</contrib-id>
                    <name>
                      <surname>Ji</surname>
                      <given-names>Guohua</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution>The National Natural Science Foundation of China</institution>
                  </funding-source>
                  <award-id>21635001, 31800707, 31800998</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6023-2258</contrib-id>
                    <name>
                      <surname>Ji</surname>
                      <given-names>Guohua</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>This work was supported by The Foundation of State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center (SMFA17A03, SMFA19B02, SMFA19K08, SMFA20A01), The National Natural Science Foundation of China (21635001, 31800707, 31800998). The funders had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="4"/>
                <table-count count="5"/>
                <page-count count="18"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>All relevant data are within the paper and its <xref rid="sec020" ref-type="sec">Supporting Information</xref> files.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>All relevant data are within the paper and its <xref rid="sec020" ref-type="sec">Supporting Information</xref> files.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>Introduction</title>
              <p>Long-term space travel would adversely affect human physiology, and the most common detrimental effects include the visually impaired intracranial pressure syndrome, decreased bone density, muscle atrophy, brain functional and structural changes [<xref rid="pone.0265108.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0265108.ref002" ref-type="bibr">2</xref>]. Since spaceflight missions are rare, the ground based analogues have been developed to simulate the space environment. Animal tail suspension is a classical and useful approach for the microgravity study on Earth for a long time [<xref rid="pone.0265108.ref003" ref-type="bibr">3</xref>–<xref rid="pone.0265108.ref005" ref-type="bibr">5</xref>]. There have been several reports about the impacts of simulated microgravity (SM) on brain cognitive function. Lin et al. demonstrated that SM inhibits the proliferation of adult hippocampal neural stem cells in rats, which maybe the reason of detrimental effects of SM on learning and memory [<xref rid="pone.0265108.ref006" ref-type="bibr">6</xref>]. Nday et al. summarized the recently published articles and concluded that the effects of SM on brain include brain plasticity, brain neurotrophic factor (GDNF), apoptosis factors (Bcl-xL and Bax), 5-hydroxytryptamine and dopaminergic system, and dopaminergic gene expression. The neuropathological characteristics of animal SM model can be comparable to the effects of aging, anxiety and other neurological diseases [<xref rid="pone.0265108.ref007" ref-type="bibr">7</xref>]. Our previous research also found that tail suspension can damage the learning and memory ability of rats, and the molecules involved in glutamate excitotoxicity and several neurotransmitters (5-hydroxytryptamine, dopamine, γ-amino acid butyric acid and epinephrine) are downregulated [<xref rid="pone.0265108.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0265108.ref008" ref-type="bibr">8</xref>].</p>
              <p>Mitochondria are essential for aerobic eukaryotes and are the most important energy supply organelles [<xref rid="pone.0265108.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0265108.ref010" ref-type="bibr">10</xref>]. Mitochondria participate in key central metabolic pathways, and are fully integrated into intracellular signaling networks that regulate multiple cellular functions, including ATP production, regulation of excitotoxicity, intracellular Ca<sup>2+</sup> homeostasis, production of reactive oxygen species, release of cytochrome c and induction of cell apoptosis [<xref rid="pone.0265108.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0265108.ref012" ref-type="bibr">12</xref>]. The human mitochondrial genome (mtDNA) contains only 37 genes that encode 13 proteins [<xref rid="pone.0265108.ref013" ref-type="bibr">13</xref>]. The remaining thousands of mitochondrial proteins are encoded by the nuclear genome. Therefore, compared with the mtDNA, the mitochondrial proteome can provide a more comprehensive perspective for understanding mitochondrial functions. Multi-omics analysis of the hundreds of data from spaceflight for astronauts and rodents revealed that the mitochondrial processes as well as innate immunity, chronic inflammation, cell cycle, circadian rhythm, and olfactory functions are the most significant enrichment processes, and mitochondrial stress is the central biological hub of the impact of spaceflight on human beings [<xref rid="pone.0265108.ref014" ref-type="bibr">14</xref>]. However, the effect of SM on the hippocampus mitochondrial proteome has not been explored.</p>
              <p>The mitochondrial dysfunction has also been demonstrated to participate in several diseases such as Alzheimer’s disease [<xref rid="pone.0265108.ref015" ref-type="bibr">15</xref>], cancers [<xref rid="pone.0265108.ref016" ref-type="bibr">16</xref>], cardiovascular diseases [<xref rid="pone.0265108.ref017" ref-type="bibr">17</xref>], Parkinson disease [<xref rid="pone.0265108.ref018" ref-type="bibr">18</xref>], traumatic brain injury and epilepsy [<xref rid="pone.0265108.ref019" ref-type="bibr">19</xref>, <xref rid="pone.0265108.ref020" ref-type="bibr">20</xref>] etc. Therefore, the study on the mechanism of mitochondrial dysfunction would be benefit for astronauts as well as the health of people on Earth. Herein, we examined the changes in the rat hippocampus mitochondrial proteome caused by the 28-day tail suspension, and performed Gene Ontology (GO) classification, pathway enrichment and protein-protein interaction analysis on the differentially expressed proteins (DEPs). Our research can provide inspiration for understanding the mitochondrial-related molecular mechanism of cognitive function decline in microgravity.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec002">
              <title>Materials and methods</title>
              <sec id="sec003">
                <title>Animals and SM model construction</title>
                <p>Eight weeks male Sprague-Dawley (SD) rats of SPF grade were purchased from Beijing Vital River Laboratory Animal Technology Co. Ltd., China. All rats were kept in separate cages and placed in a temperature controlled environment. The light dark cycle was 12/12 hours, and they had free access to food and water. All experimental procedures were approved by the Animal Care and Use Committee of China Astronaut Research and Training Center. After 2 weeks of adaptive feeding, the rats were randomly divided into two groups, Control group (C) and SM group (T), and each group contained 24 rats. The method of tail suspension to SM effect was described previously [<xref rid="pone.0265108.ref021" ref-type="bibr">21</xref>], and the Control group was raised in the identical cages without tail suspension. After 28 days of tail suspension, the animals were anesthetized by intraperitoneal injection of 10% chloral hydrate (2.5 ml/kg) and sacrificed by cervical dislocation. All efforts were made to minimize the discomfort of the animals.</p>
              </sec>
              <sec id="sec004">
                <title>Transmission electron microscopy</title>
                <p>After 28 days of tail suspension, the rat was euthanized by cervical dislocation and the brain was removed. The hippocampus tissue was separated on ice and cut into approximately 1mm<sup>3</sup> tissue pieces, which were quickly placed in 2.5% glutaraldehyde fixative solution and fixed at 4°C overnight. Samples were rinsed three times with phosphate buffer (0.1M, pH 7.0), then fixed with 1% osmium acid solution for 2h, rinsed again with phosphate buffer for three times, and dehydrated with gradient ethanol, put in epoxy resin, treated at 80°C for 24h to polymerize, then cut into 100nm ultra-thin sections and dyed with uranyl acetate and lead citrate. Finally it was observed under a transmission electron microscope (Hitachi, Japan). The number of mitochondria in each neuronal soma was counted from at least 10 cells in each group. The micrographs were tracked respectively, and the shape and size parameters were obtained by ImageJ software. The surface area representing the size of mitochondria was reported in squared micrometers (μm<sup>2</sup>), and Ferret’s diameter was measured by the longest distance between two points within a mitochondria.</p>
              </sec>
              <sec id="sec005">
                <title>Isolation of mitochondria</title>
                <p>Fifteen rats were randomly taken out from the tail suspension and control groups. After separating the hippocampus, the left and right hippocampus of five randomly selected rats were mixed together to form a sample. The mitochondria were extracted by Mitochondrial Isolation Kit (MP-007, Invent, USA) according to the manufacture’s instructions. Protein concentrations were quantified by BCA assay (Thermo Fischer, USA).</p>
              </sec>
              <sec id="sec006">
                <title>TMT-based proteomics analysis</title>
                <sec id="sec007">
                  <title>Protein processing</title>
                  <p>Dissolved the mitochondria with Protein Solubilization Reagent for MS (WA-011, Invent, USA). Added the DTT to the sample to a final concentration of 10mM and reduced in the oven at 55°C for 1h. After the samples returning to the room temperature, added the IAM at a final concentration of 40mM, and reacted for 30min in dark. Centrifuged with a 10kda ultrafiltration tube at 12000g, and added 200μl of 100mM TEAB to the samples, then added trypsin according to 1/50 of the protein mass, and kept in a water bath at 37°C overnight. The next day, washed 3 times with ultrapure water and freeze-dried at the bottom of the enrichment tube.</p>
                </sec>
                <sec id="sec008">
                  <title>TMT labelling</title>
                  <p>Re-dissolved the peptides with 200μl of 200mM TEAB, and then quantified them with NanoDrop (Thermo Fisher, USA). Taking 25μg of peptides from each sample and labelled them with TMT reagent at room temperature for 1 hour. The labeled samples were as follows: the Control group, labeled with 126, 127N and 128N; the SM group, labeled with 129N, 130N and 131. Then added 5μl of 5% ammonia water for quenching, mixed and reacted at room temperature for 15 minutes, and then mixed 5 labeled samples from same group together and evaporated to dryness at 60°C by a concentrator.</p>
                </sec>
                <sec id="sec009">
                  <title>HPLC liquid phase separation</title>
                  <p>Prepared mobile phase A liquid (2% acetonitrile, 98% water, ammonia water adjusted to pH = 10) and B liquid (98% acetonitrile, 2% water, ammonia water adjusted to pH = 10). Used 150μl of solution A to dissolve the lyophilized powder of the sample, centrifuged at 12000g for 10min at room temperature, and took the supernatant for injection. The TMT labelled peptide mixture was fractionated by a Durashell column from Agela (4.6mm×250mm i.d, C18, 5μm) by L-3000 HPLC system (Rigol, China). A total of 100 tubes were collected with the speed of 1 tube per minute, and finally combined into 10 fractions. All fractions were dried by a rotary vacuum concentrator.</p>
                </sec>
                <sec id="sec010">
                  <title>LC-MS/MS analysis</title>
                  <p>The TMT-labeled sample of each fraction was resuspended in 2% acetonitrile, 98% water and 0.1% FA, after centrifuged at 12000g for 3min, 10μl of supernatant was loaded onto an Eksigent Nano LC 2D plus HPLC by the autosampler onto a 5μm C18 trap column (ID100μm, 20mm length). The peptides were then eluted onto a 3μm analytical C18 column (ID75μm, 120mm length) packed in-house. Separation was run at 330 nl/min starting from 5% B2 (98% ACN+1.9% H2O+0.1% FA), followed by stepwise gradient (8% B2 for 5min, 22% B2 for 34min, 32% B2 for 41min, 90% B2 for 42min), maintained at 90% B2 for another 46min, and finally returned to 5% B2 for 1min. LC-MS/MS analysis was performed on a Q Exactive HF mass spectrometer (Thermo Fisher, USA). The mass spectrometry parameters were set as follows: the first-level M/Z scan range was 300–1400, the resolution was 120,000, the AGC target was 3e6, the maximum ion injection time was 80ms, 15 precursor ions were selected for secondary fragmentation, and the secondary resolution was 60000. The AGC target was 5e4, the maximum ion injection time was 20ms, and the precursor ion window was set to 1.2M/Z. Proteome Discoverer (version 2.3.1.15, Thermo Fisher Scientific, USA) was used for data retrieval of raw data. The database used was downloaded from uniprotKB (including TrEMBL entries) on August 13, 2020, containing 20289 sequence information, and was also downloaded from Uniprot_Rat (version 2019.04.20). Andromeda search engine was used with the following settings: trypsin cleavage; fixed modification of carbamidomethylation of cysteine; variable modifications of oxidation of methionine; acetylation modification at the N-terminal of protein, the primary mass error was set at 20ppm and the secondary mass error was set at 20mmu; a maximum of two missed cleavage. The false discovery rate was calculated by decoy database searching. For protein identification, the peptides were of minimum 6 amino acids and had at least 1 unique peptide identified per protein. A false discovery rate (FDR) of 1% at both peptide and protein level was used. Normalization was performed against the total peptide amount.</p>
                </sec>
              </sec>
              <sec id="sec011">
                <title>Analysis of mitochondrial proteome</title>
                <p>In order to determine the possible biological functions of DEPs, DAVID Bioinformatics Resources were used to conduct gene ontology (GO) analysis in biological processes, cell components and molecular functions. The Kyoto Encyclopedia of Genes and Genomes (KEGG: <ext-link xlink:href="http://www.genome.jp/kegg/" ext-link-type="uri">http://www.genome.jp/kegg/</ext-link>) analysis was also conducted. The protein-protein interaction (PPI) network was constructed using the STRING database and Cytoscape.</p>
              </sec>
              <sec id="sec012">
                <title>Western blotting</title>
                <p>Mitochondria extraction and dissolution were conducted as described above, and the protein concentration was determined with BCA Protein Assay Kit (Thermo Fisher, USA). Western blot analyses were performed according to standard procedures. The primary antibodies used were aconitate hydratase (ACO2, 6571), dihydrolipoamide S-succinyltransferase (DLST, 11954), citrate synthase (CS, 14309), and VDAC (4661), and all of the antibodies were purchased from Cell Signaling Technology, Danvers, MA, USA. The immunoblot images were analyzed with ImageJ to determine the relative integrated density, and the relative expressions of ACO2, DLST and CS were represented by the intensity ratio between the interested protein and the loading control (VDAC) in each loading lane.</p>
              </sec>
              <sec id="sec013">
                <title>Statistical analysis</title>
                <p>The data were expressed as mean±standard deviation (SD) or fold change (FC) relative to the corresponding control group. Statistical analysis was performed using two tailed Student’s t-test. The Fisher’s exact test was used to evaluate the significance of GO terms and Pathway enrichment, with correction for multiple comparisons based on the false discovery rate (FDR). A p-value or FDR less than 0.05 were considered statistically significant.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec014">
              <title>Results</title>
              <sec id="sec015">
                <title>Mitochondrial dynamics and morphology are changed by 28-day SM</title>
                <p>We studied the influence of SM on the dynamics and morphology of mitochondria in hippocampal neuronal soma using transmission electron microscopy. It was found that the mitochondrial swelling was obvious, and the cristae were loose and dissolved in the SM group, while the mitochondrial structure in the Control group was basically normal, the membrane shape was complete, and the cristae were dense and regular (<bold><xref rid="pone.0265108.g001" ref-type="fig">Fig 1A–1D</xref></bold>). The number of mitochondria in the SM group was significantly increased compared to the Control group (p&lt;0.001), which was reflected by the elevated surface area and the lengthened Feret’s diameter (<bold><xref rid="pone.0265108.g001" ref-type="fig">Fig 1E–1G</xref></bold>). These data suggest that the function of mitochondria in the rat hippocampal neuronal soma is changed under the 28-day SM condition.</p>
                <fig position="float" id="pone.0265108.g001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0265108.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>Effects of SM on mitochondrial morphology and dynamics of hippocampal neuronal soma in rats.</title>
                    <p>Rats were tail suspended for 28 days, and the mitochondria in hippocampal neuronal soma were observed under transmission electron microscope. <bold>(A, B)</bold> Zoom 20,000 times. n = 6. <bold>(C, D)</bold> Zoom 50,000 times. <bold>(E)</bold> Mitochondria per cell were counted. n≥10 images per group. <bold>(F, G)</bold> mitochondrial mean surface area and Feret’s diameter on transmission electron microscopy images. n = 25. C and T represented the Control group and SM group samples respectively. ***p&lt;0.001.</p>
                  </caption>
                  <graphic xlink:href="pone.0265108.g001" position="float"/>
                </fig>
              </sec>
              <sec id="sec016">
                <title>The mitochondrial proteome of hippocampus is altered by SM</title>
                <p>To evaluate the changes in hippocampus mitochondrial protein expression, we performed TMT-based proteomics analysis on the SM group and Control group samples. The heatmap plot disclosed that a total of 4,044 proteins were quantified across all samples, and the hippocampus mitochondrial protein expression was altered significantly by SM (<bold><xref rid="pone.0265108.g002" ref-type="fig">Fig 2A</xref></bold>). A fold change cutoff value of ≥1.5 or ≤0.67 was defined as up- or down-regulation, and only proteins that were identified by three or more peptides with &gt;1.5-fold changes and statistically significant (p value≤0.05) were considered to be DEPs. Among the 163 DEPs, 128 proteins were upregulated in the SM group compared with the Control group, whereas 35 proteins were downregulated (<bold><xref rid="pone.0265108.g002" ref-type="fig">Fig 2B</xref></bold>). The gene and protein names, fold change and p-value of DEPs were listed in <bold><xref rid="pone.0265108.t001" ref-type="table">Table 1</xref></bold> and <bold><xref rid="pone.0265108.s002" ref-type="supplementary-material">S1 Table</xref></bold>.</p>
                <fig position="float" id="pone.0265108.g002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0265108.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>The overview of global changes of identified proteins.</title>
                    <p><bold>(A)</bold> The identified proteins expression profile by heatmap plot. T1, T2 and T3, and C1, C2 and C3 respectively represented 3 tail suspension samples and 3 control samples. <bold>(B)</bold> Volcano plots of fold-change vs. -log<sub>10</sub> p-value of identified proteins. The significance threshold was set at p-value≤0.05. The significant differentially expressed proteins were marked with different colors, the upregulated proteins were marked in pink, downregulated proteins were marked in green, and blue dots indicated no significant difference. FC, fold change.</p>
                  </caption>
                  <graphic xlink:href="pone.0265108.g002" position="float"/>
                </fig>
                <table-wrap position="float" id="pone.0265108.t001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0265108.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>The protein changes of mitochondria of hippocampus after 28 days of tail suspension in rats.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0265108.t001" id="pone.0265108.t001g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">ID</th>
                          <th align="center" rowspan="1" colspan="1">Accession</th>
                          <th align="center" rowspan="1" colspan="1">Gene name</th>
                          <th align="center" rowspan="1" colspan="1">Protein name</th>
                          <th align="center" rowspan="1" colspan="1">Fold change</th>
                          <th align="center" rowspan="1" colspan="1">p-value</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JYW6_RAT</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">Uncharacterized protein</td>
                          <td align="center" rowspan="1" colspan="1">2.35</td>
                          <td align="center" rowspan="1" colspan="1">0.008939</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">HOT_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q4QQW3</td>
                          <td align="center" rowspan="1" colspan="1">Adhfe1</td>
                          <td align="center" rowspan="1" colspan="1">Hydroxyacid-oxoacid transhydrogenase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">2.07</td>
                          <td align="center" rowspan="1" colspan="1">0.002111</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V8U8_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V8U8</td>
                          <td align="center" rowspan="1" colspan="1">Bcat2</td>
                          <td align="center" rowspan="1" colspan="1">Branched-chain-amino-acid aminotransferase</td>
                          <td align="center" rowspan="1" colspan="1">2.02</td>
                          <td align="center" rowspan="1" colspan="1">0.001467</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">SODM_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P07895</td>
                          <td align="center" rowspan="1" colspan="1">Sod2</td>
                          <td align="center" rowspan="1" colspan="1">Superoxide dismutase [Mn], mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">2.01</td>
                          <td align="center" rowspan="1" colspan="1">0.00258</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">ATP6_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P05504</td>
                          <td align="center" rowspan="1" colspan="1">Mt-atp6</td>
                          <td align="center" rowspan="1" colspan="1">ATP synthase subunit a</td>
                          <td align="center" rowspan="1" colspan="1">1.96</td>
                          <td align="center" rowspan="1" colspan="1">0.02367</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">AATM_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P00507</td>
                          <td align="center" rowspan="1" colspan="1">Got2</td>
                          <td align="center" rowspan="1" colspan="1">Aspartate aminotransferase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.95</td>
                          <td align="center" rowspan="1" colspan="1">0.013689</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">CH10_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P26772</td>
                          <td align="center" rowspan="1" colspan="1">Hspe1</td>
                          <td align="center" rowspan="1" colspan="1">10 kDa heat shock protein, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.92</td>
                          <td align="center" rowspan="1" colspan="1">0.001314</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GCSH_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q5I0P2</td>
                          <td align="center" rowspan="1" colspan="1">Gcsh</td>
                          <td align="center" rowspan="1" colspan="1">Glycine cleavage system H protein, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.90</td>
                          <td align="center" rowspan="1" colspan="1">0.002974</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">TRXR2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q9Z0J5</td>
                          <td align="center" rowspan="1" colspan="1">Txnrd2</td>
                          <td align="center" rowspan="1" colspan="1">Thioredoxin reductase 2, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.88</td>
                          <td align="center" rowspan="1" colspan="1">0.040301</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V936_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V936</td>
                          <td align="center" rowspan="1" colspan="1">Cs</td>
                          <td align="center" rowspan="1" colspan="1">Citrate synthase</td>
                          <td align="center" rowspan="1" colspan="1">1.85</td>
                          <td align="center" rowspan="1" colspan="1">0.00148</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D3ZT98_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D3ZT98</td>
                          <td align="center" rowspan="1" colspan="1">Bola3</td>
                          <td align="center" rowspan="1" colspan="1">BolA family member 3</td>
                          <td align="center" rowspan="1" colspan="1">1.83</td>
                          <td align="center" rowspan="1" colspan="1">0.003921</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GABT_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P50554</td>
                          <td align="center" rowspan="1" colspan="1">Abat</td>
                          <td align="center" rowspan="1" colspan="1">4-aminobutyrate aminotransferase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.82</td>
                          <td align="center" rowspan="1" colspan="1">0.000839</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2K2Q2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2K2Q2</td>
                          <td align="center" rowspan="1" colspan="1">Gcat</td>
                          <td align="center" rowspan="1" colspan="1">Glycine C-acetyltransferase</td>
                          <td align="center" rowspan="1" colspan="1">1.81</td>
                          <td align="center" rowspan="1" colspan="1">0.024635</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">AUHM_RAT</td>
                          <td align="center" rowspan="1" colspan="1">F1LU71</td>
                          <td align="center" rowspan="1" colspan="1">Auh</td>
                          <td align="center" rowspan="1" colspan="1">Methylglutaconyl-CoA hydratase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.79</td>
                          <td align="center" rowspan="1" colspan="1">0.004409</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">ES1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P56571</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">ES1 protein homolog, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.79</td>
                          <td align="center" rowspan="1" colspan="1">0.001447</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">FAHD1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q6AYQ8</td>
                          <td align="center" rowspan="1" colspan="1">Fahd1</td>
                          <td align="center" rowspan="1" colspan="1">Acylpyruvase FAHD1, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.78</td>
                          <td align="center" rowspan="1" colspan="1">0.006231</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V945_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V945</td>
                          <td align="center" rowspan="1" colspan="1">Aldh5a1</td>
                          <td align="center" rowspan="1" colspan="1">Succinate-semialdehyde dehydrogenase</td>
                          <td align="center" rowspan="1" colspan="1">1.77</td>
                          <td align="center" rowspan="1" colspan="1">0.015407</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JVW3_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JVW3</td>
                          <td align="center" rowspan="1" colspan="1">Ankrd17</td>
                          <td align="center" rowspan="1" colspan="1">Ankyrin repeat domain 17</td>
                          <td align="center" rowspan="1" colspan="1">1.77</td>
                          <td align="center" rowspan="1" colspan="1">0.015563</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">IDHP_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P56574</td>
                          <td align="center" rowspan="1" colspan="1">Idh2</td>
                          <td align="center" rowspan="1" colspan="1">Isocitrate dehydrogenase [NADP], mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.77</td>
                          <td align="center" rowspan="1" colspan="1">0.003087</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">DHE3_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P10860</td>
                          <td align="center" rowspan="1" colspan="1">Glud1</td>
                          <td align="center" rowspan="1" colspan="1">Glutamate dehydrogenase 1, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.77</td>
                          <td align="center" rowspan="1" colspan="1">0.001715</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">F1LN88_RAT</td>
                          <td align="center" rowspan="1" colspan="1">F1LN88</td>
                          <td align="center" rowspan="1" colspan="1">Aldh2</td>
                          <td align="center" rowspan="1" colspan="1">Aldehyde dehydrogenase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.75</td>
                          <td align="center" rowspan="1" colspan="1">0.00937</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">IVD_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P12007</td>
                          <td align="center" rowspan="1" colspan="1">Ivd</td>
                          <td align="center" rowspan="1" colspan="1">Isovaleryl-CoA dehydrogenase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.73</td>
                          <td align="center" rowspan="1" colspan="1">0.008189</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">THTR_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P24329</td>
                          <td align="center" rowspan="1" colspan="1">Tst</td>
                          <td align="center" rowspan="1" colspan="1">Thiosulfate sulfurtransferase</td>
                          <td align="center" rowspan="1" colspan="1">1.73</td>
                          <td align="center" rowspan="1" colspan="1">0.009805</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">ECHM_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P14604</td>
                          <td align="center" rowspan="1" colspan="1">Echs1</td>
                          <td align="center" rowspan="1" colspan="1">Enoyl-CoA hydratase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.72</td>
                          <td align="center" rowspan="1" colspan="1">0.001788</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">ACON_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q9ER34</td>
                          <td align="center" rowspan="1" colspan="1">Aco2</td>
                          <td align="center" rowspan="1" colspan="1">Aconitate hydratase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.71</td>
                          <td align="center" rowspan="1" colspan="1">0.002251</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">CALR_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P18418</td>
                          <td align="center" rowspan="1" colspan="1">Calr</td>
                          <td align="center" rowspan="1" colspan="1">Calreticulin</td>
                          <td align="center" rowspan="1" colspan="1">1.71</td>
                          <td align="center" rowspan="1" colspan="1">0.00505</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">PPIF_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P29117</td>
                          <td align="center" rowspan="1" colspan="1">Ppif</td>
                          <td align="center" rowspan="1" colspan="1">Peptidyl-prolyl cis-trans isomerase F, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.70</td>
                          <td align="center" rowspan="1" colspan="1">0.002718</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">B2RYT0_RAT</td>
                          <td align="center" rowspan="1" colspan="1">B2RYT0</td>
                          <td align="center" rowspan="1" colspan="1">Mrps21</td>
                          <td align="center" rowspan="1" colspan="1">Mitochondrial ribosomal protein S21</td>
                          <td align="center" rowspan="1" colspan="1">1.70</td>
                          <td align="center" rowspan="1" colspan="1">0.010777</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D4A5F4_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D4A5F4</td>
                          <td align="center" rowspan="1" colspan="1">RGD1311575</td>
                          <td align="center" rowspan="1" colspan="1">Hypothetical LOC289568</td>
                          <td align="center" rowspan="1" colspan="1">1.70</td>
                          <td align="center" rowspan="1" colspan="1">0.013594</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">ECH1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q62651</td>
                          <td align="center" rowspan="1" colspan="1">Ech1</td>
                          <td align="center" rowspan="1" colspan="1">Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.69</td>
                          <td align="center" rowspan="1" colspan="1">0.006191</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">ETFA_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P13803</td>
                          <td align="center" rowspan="1" colspan="1">Etfa</td>
                          <td align="center" rowspan="1" colspan="1">Electron transfer flavoprotein subunit alpha, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.69</td>
                          <td align="center" rowspan="1" colspan="1">0.002644</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V9U2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V9U2</td>
                          <td align="center" rowspan="1" colspan="1">Acaa2</td>
                          <td align="center" rowspan="1" colspan="1">3-ketoacyl-CoA thiolase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.69</td>
                          <td align="center" rowspan="1" colspan="1">0.001865</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D4A7X5_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D4A7X5</td>
                          <td align="center" rowspan="1" colspan="1">Ppm1k</td>
                          <td align="center" rowspan="1" colspan="1">Protein phosphatase 1K (PP2C domain containing) (Predicted)</td>
                          <td align="center" rowspan="1" colspan="1">1.68</td>
                          <td align="center" rowspan="1" colspan="1">0.006727</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">KNG1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P08934</td>
                          <td align="center" rowspan="1" colspan="1">Kng1</td>
                          <td align="center" rowspan="1" colspan="1">Kininogen-1</td>
                          <td align="center" rowspan="1" colspan="1">1.68</td>
                          <td align="center" rowspan="1" colspan="1">0.038332</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V7I0_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V7I0</td>
                          <td align="center" rowspan="1" colspan="1">Prdx3</td>
                          <td align="center" rowspan="1" colspan="1">Peroxiredoxin 3</td>
                          <td align="center" rowspan="1" colspan="1">1.67</td>
                          <td align="center" rowspan="1" colspan="1">0.003211</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">F1LNF7_RAT</td>
                          <td align="center" rowspan="1" colspan="1">F1LNF7</td>
                          <td align="center" rowspan="1" colspan="1">Idh3a</td>
                          <td align="center" rowspan="1" colspan="1">Isocitrate dehydrogenase [NAD] subunit, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.67</td>
                          <td align="center" rowspan="1" colspan="1">0.005636</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">Q6IMX3_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q6IMX3</td>
                          <td align="center" rowspan="1" colspan="1">Acads</td>
                          <td align="center" rowspan="1" colspan="1">Acetyl-Coenzyme A dehydrogenase, short chain, isoform CRA_a</td>
                          <td align="center" rowspan="1" colspan="1">1.67</td>
                          <td align="center" rowspan="1" colspan="1">0.01089</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JVM0_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JVM0</td>
                          <td align="center" rowspan="1" colspan="1">Aldh4a1</td>
                          <td align="center" rowspan="1" colspan="1">Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.66</td>
                          <td align="center" rowspan="1" colspan="1">0.007541</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D4A8N2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D4A8N2</td>
                          <td align="center" rowspan="1" colspan="1">Fdx2</td>
                          <td align="center" rowspan="1" colspan="1">Ferredoxin 2</td>
                          <td align="center" rowspan="1" colspan="1">1.66</td>
                          <td align="center" rowspan="1" colspan="1">0.0146</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JZA2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JZA2</td>
                          <td align="center" rowspan="1" colspan="1">Grpel1</td>
                          <td align="center" rowspan="1" colspan="1">GrpE protein homolog</td>
                          <td align="center" rowspan="1" colspan="1">1.66</td>
                          <td align="center" rowspan="1" colspan="1">0.02531</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">3HIDH_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P29266</td>
                          <td align="center" rowspan="1" colspan="1">Hibadh</td>
                          <td align="center" rowspan="1" colspan="1">3-hydroxyisobutyrate dehydrogenase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.66</td>
                          <td align="center" rowspan="1" colspan="1">0.001062</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">MESD_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q5U2R7</td>
                          <td align="center" rowspan="1" colspan="1">Mesd</td>
                          <td align="center" rowspan="1" colspan="1">LRP chaperone MESD</td>
                          <td align="center" rowspan="1" colspan="1">1.65</td>
                          <td align="center" rowspan="1" colspan="1">0.010713</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GATA_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q5FWT5</td>
                          <td align="center" rowspan="1" colspan="1">Qrsl1</td>
                          <td align="center" rowspan="1" colspan="1">Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.65</td>
                          <td align="center" rowspan="1" colspan="1">0.014454</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">FUMH_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P14408</td>
                          <td align="center" rowspan="1" colspan="1">Fh</td>
                          <td align="center" rowspan="1" colspan="1">Fumarate hydratase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.65</td>
                          <td align="center" rowspan="1" colspan="1">0.000491</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2K9G3_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2K9G3</td>
                          <td align="center" rowspan="1" colspan="1">Mrps24</td>
                          <td align="center" rowspan="1" colspan="1">Mitochondrial ribosomal protein S24</td>
                          <td align="center" rowspan="1" colspan="1">1.65</td>
                          <td align="center" rowspan="1" colspan="1">0.00209</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D4ADD7_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D4ADD7</td>
                          <td align="center" rowspan="1" colspan="1">Glrx5</td>
                          <td align="center" rowspan="1" colspan="1">Glutaredoxin 5</td>
                          <td align="center" rowspan="1" colspan="1">1.65</td>
                          <td align="center" rowspan="1" colspan="1">0.013459</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">Q6AXY8_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q6AXY8</td>
                          <td align="center" rowspan="1" colspan="1">Dhrs1</td>
                          <td align="center" rowspan="1" colspan="1">Dehydrogenase/reductase (SDR family) member 1</td>
                          <td align="center" rowspan="1" colspan="1">1.63</td>
                          <td align="center" rowspan="1" colspan="1">0.039263</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">MDHM_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P04636</td>
                          <td align="center" rowspan="1" colspan="1">Mdh2</td>
                          <td align="center" rowspan="1" colspan="1">Malate dehydrogenase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.63</td>
                          <td align="center" rowspan="1" colspan="1">0.007061</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V7J0_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V7J0</td>
                          <td align="center" rowspan="1" colspan="1">Aldh6a1</td>
                          <td align="center" rowspan="1" colspan="1">Aldehyde dehydrogenase family 6, subfamily A1, isoform CRA_b</td>
                          <td align="center" rowspan="1" colspan="1">1.63</td>
                          <td align="center" rowspan="1" colspan="1">0.013342</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">MAAI_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P57113</td>
                          <td align="center" rowspan="1" colspan="1">Gstz1</td>
                          <td align="center" rowspan="1" colspan="1">Maleylacetoacetate isomerase</td>
                          <td align="center" rowspan="1" colspan="1">1.63</td>
                          <td align="center" rowspan="1" colspan="1">0.018412</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">ACADL_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P15650</td>
                          <td align="center" rowspan="1" colspan="1">Acadl</td>
                          <td align="center" rowspan="1" colspan="1">Long-chain specific acyl-CoA dehydrogenase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.62</td>
                          <td align="center" rowspan="1" colspan="1">0.002101</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">LYRM9_RAT</td>
                          <td align="center" rowspan="1" colspan="1">B2RZD7</td>
                          <td align="center" rowspan="1" colspan="1">Lyrm9</td>
                          <td align="center" rowspan="1" colspan="1">LYR motif-containing protein 9</td>
                          <td align="center" rowspan="1" colspan="1">1.62</td>
                          <td align="center" rowspan="1" colspan="1">0.001083</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">THIL_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P17764</td>
                          <td align="center" rowspan="1" colspan="1">Acat1</td>
                          <td align="center" rowspan="1" colspan="1">Acetyl-CoA acetyltransferase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.62</td>
                          <td align="center" rowspan="1" colspan="1">0.008093</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">MANF_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P0C5H9</td>
                          <td align="center" rowspan="1" colspan="1">Manf</td>
                          <td align="center" rowspan="1" colspan="1">Mesencephalic astrocyte-derived neurotrophic factor</td>
                          <td align="center" rowspan="1" colspan="1">1.62</td>
                          <td align="center" rowspan="1" colspan="1">0.008521</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">F1M5N4_RAT</td>
                          <td align="center" rowspan="1" colspan="1">F1M5N4</td>
                          <td align="center" rowspan="1" colspan="1">Me3</td>
                          <td align="center" rowspan="1" colspan="1">Malic enzyme</td>
                          <td align="center" rowspan="1" colspan="1">1.62</td>
                          <td align="center" rowspan="1" colspan="1">0.005954</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D4A0Y4_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D4A0Y4</td>
                          <td align="center" rowspan="1" colspan="1">Oxnad1</td>
                          <td align="center" rowspan="1" colspan="1">Oxidoreductase NAD-binding domain containing 1 (Predicted), isoform CRA_b</td>
                          <td align="center" rowspan="1" colspan="1">1.61</td>
                          <td align="center" rowspan="1" colspan="1">0.001023</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0A0MXW1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0A0MXW1</td>
                          <td align="center" rowspan="1" colspan="1">Bckdhb</td>
                          <td align="center" rowspan="1" colspan="1">2-oxoisovalerate dehydrogenase subunit beta, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.61</td>
                          <td align="center" rowspan="1" colspan="1">0.006284</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V796_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V796</td>
                          <td align="center" rowspan="1" colspan="1">Acadm</td>
                          <td align="center" rowspan="1" colspan="1">Acetyl-Coenzyme A dehydrogenase, medium chain</td>
                          <td align="center" rowspan="1" colspan="1">1.61</td>
                          <td align="center" rowspan="1" colspan="1">0.0034</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2K5F1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2K5F1</td>
                          <td align="center" rowspan="1" colspan="1">Macrod1</td>
                          <td align="center" rowspan="1" colspan="1">ADP-ribose glycohydrolase MACROD1</td>
                          <td align="center" rowspan="1" colspan="1">1.61</td>
                          <td align="center" rowspan="1" colspan="1">0.018189</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">IDH3B_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q68FX0</td>
                          <td align="center" rowspan="1" colspan="1">Idh3B</td>
                          <td align="center" rowspan="1" colspan="1">Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.60</td>
                          <td align="center" rowspan="1" colspan="1">0.002549</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V7I5_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V7I5</td>
                          <td align="center" rowspan="1" colspan="1">Aldh1b1</td>
                          <td align="center" rowspan="1" colspan="1">Aldehyde dehydrogenase X, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.60</td>
                          <td align="center" rowspan="1" colspan="1">0.006674</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D3ZKG1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D3ZKG1</td>
                          <td align="center" rowspan="1" colspan="1">Mmut</td>
                          <td align="center" rowspan="1" colspan="1">Methylmalonyl CoA mutase</td>
                          <td align="center" rowspan="1" colspan="1">1.60</td>
                          <td align="center" rowspan="1" colspan="1">0.015932</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">F210A_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q5XIJ4</td>
                          <td align="center" rowspan="1" colspan="1">Fam210a</td>
                          <td align="center" rowspan="1" colspan="1">Protein FAM210A</td>
                          <td align="center" rowspan="1" colspan="1">1.60</td>
                          <td align="center" rowspan="1" colspan="1">0.013908</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">FMT_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q5I0C5</td>
                          <td align="center" rowspan="1" colspan="1">Mtfmt</td>
                          <td align="center" rowspan="1" colspan="1">Methionyl-tRNA formyltransferase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.60</td>
                          <td align="center" rowspan="1" colspan="1">0.018123</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">CEGT_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q9R0E0</td>
                          <td align="center" rowspan="1" colspan="1">Ugcg</td>
                          <td align="center" rowspan="1" colspan="1">Ceramide glucosyltransferase</td>
                          <td align="center" rowspan="1" colspan="1">1.60</td>
                          <td align="center" rowspan="1" colspan="1">0.020969</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0H2UI21_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0H2UI21</td>
                          <td align="center" rowspan="1" colspan="1">Crat</td>
                          <td align="center" rowspan="1" colspan="1">Carnitine O-acetyltransferase</td>
                          <td align="center" rowspan="1" colspan="1">1.59</td>
                          <td align="center" rowspan="1" colspan="1">0.011738</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">M0R3V4_RAT</td>
                          <td align="center" rowspan="1" colspan="1">M0R3V4</td>
                          <td align="center" rowspan="1" colspan="1">Mydgf</td>
                          <td align="center" rowspan="1" colspan="1">Myeloid-derived growth factor</td>
                          <td align="center" rowspan="1" colspan="1">1.59</td>
                          <td align="center" rowspan="1" colspan="1">0.010141</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">OAT_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P04182</td>
                          <td align="center" rowspan="1" colspan="1">Oat</td>
                          <td align="center" rowspan="1" colspan="1">Ornithine aminotransferase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.59</td>
                          <td align="center" rowspan="1" colspan="1">0.024142</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">F1LPV8_RAT</td>
                          <td align="center" rowspan="1" colspan="1">F1LPV8</td>
                          <td align="center" rowspan="1" colspan="1">Suclg2</td>
                          <td align="center" rowspan="1" colspan="1">Succinate—CoA ligase [GDP-forming] subunit beta, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.59</td>
                          <td align="center" rowspan="1" colspan="1">0.005411</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JSS8_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JSS8</td>
                          <td align="center" rowspan="1" colspan="1">Prdx5</td>
                          <td align="center" rowspan="1" colspan="1">Peroxiredoxin</td>
                          <td align="center" rowspan="1" colspan="1">1.59</td>
                          <td align="center" rowspan="1" colspan="1">0.001438</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">RCN2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q62703</td>
                          <td align="center" rowspan="1" colspan="1">Rcn2</td>
                          <td align="center" rowspan="1" colspan="1">Reticulocalbin-2</td>
                          <td align="center" rowspan="1" colspan="1">1.59</td>
                          <td align="center" rowspan="1" colspan="1">0.028981</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">ATIF1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q03344</td>
                          <td align="center" rowspan="1" colspan="1">Atp5if1</td>
                          <td align="center" rowspan="1" colspan="1">ATPase inhibitor, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.58</td>
                          <td align="center" rowspan="1" colspan="1">0.037234</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">Q5U3Z7_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q5U3Z7</td>
                          <td align="center" rowspan="1" colspan="1">Shmt2</td>
                          <td align="center" rowspan="1" colspan="1">Serine hydroxymethyltransferase</td>
                          <td align="center" rowspan="1" colspan="1">1.58</td>
                          <td align="center" rowspan="1" colspan="1">0.022602</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">SCOT1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">B2GV06</td>
                          <td align="center" rowspan="1" colspan="1">Oxct1</td>
                          <td align="center" rowspan="1" colspan="1">Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.58</td>
                          <td align="center" rowspan="1" colspan="1">0.019463</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">Q68FZ8_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q68FZ8</td>
                          <td align="center" rowspan="1" colspan="1">Pccb</td>
                          <td align="center" rowspan="1" colspan="1">Propionyl coenzyme A carboxylase, beta polypeptide</td>
                          <td align="center" rowspan="1" colspan="1">1.58</td>
                          <td align="center" rowspan="1" colspan="1">0.01069</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">FAHD2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">B2RYW9</td>
                          <td align="center" rowspan="1" colspan="1">Fahd2</td>
                          <td align="center" rowspan="1" colspan="1">Fumarylacetoacetate hydrolase domain-containing protein 2</td>
                          <td align="center" rowspan="1" colspan="1">1.58</td>
                          <td align="center" rowspan="1" colspan="1">0.006075</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">F1M8H2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">F1M8H2</td>
                          <td align="center" rowspan="1" colspan="1">Wars2</td>
                          <td align="center" rowspan="1" colspan="1">Tryptophanyl tRNA synthetase 2 (mitochondrial)</td>
                          <td align="center" rowspan="1" colspan="1">1.58</td>
                          <td align="center" rowspan="1" colspan="1">0.020609</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">Q6AY99_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q6AY99</td>
                          <td align="center" rowspan="1" colspan="1">Akr1b10</td>
                          <td align="center" rowspan="1" colspan="1">Aldo-keto reductase family 1 member B10</td>
                          <td align="center" rowspan="1" colspan="1">1.57</td>
                          <td align="center" rowspan="1" colspan="1">0.015156</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0H2UHE1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0H2UHE1</td>
                          <td align="center" rowspan="1" colspan="1">Suclg1</td>
                          <td align="center" rowspan="1" colspan="1">Succinate—CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.57</td>
                          <td align="center" rowspan="1" colspan="1">0.005037</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D4A830_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D4A830</td>
                          <td align="center" rowspan="1" colspan="1">Ppa2</td>
                          <td align="center" rowspan="1" colspan="1">Pyrophosphatase (inorganic) 2</td>
                          <td align="center" rowspan="1" colspan="1">1.57</td>
                          <td align="center" rowspan="1" colspan="1">0.006482</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">F1LP30_RAT</td>
                          <td align="center" rowspan="1" colspan="1">F1LP30</td>
                          <td align="center" rowspan="1" colspan="1">Mccc1</td>
                          <td align="center" rowspan="1" colspan="1">Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.56</td>
                          <td align="center" rowspan="1" colspan="1">0.01137</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D3ZTR1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D3ZTR1</td>
                          <td align="center" rowspan="1" colspan="1">Mrps17</td>
                          <td align="center" rowspan="1" colspan="1">Mitochondrial ribosomal protein S17</td>
                          <td align="center" rowspan="1" colspan="1">1.56</td>
                          <td align="center" rowspan="1" colspan="1">0.004775</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">Q5RJR9_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q5RJR9</td>
                          <td align="center" rowspan="1" colspan="1">Serpinh1</td>
                          <td align="center" rowspan="1" colspan="1">Serine (Or cysteine) proteinase inhibitor, clade H, member 1, isoform CRA_b</td>
                          <td align="center" rowspan="1" colspan="1">1.55</td>
                          <td align="center" rowspan="1" colspan="1">0.049977</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V6T7_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V6T7</td>
                          <td align="center" rowspan="1" colspan="1">Pdia4</td>
                          <td align="center" rowspan="1" colspan="1">Protein disulfide-isomerase A4</td>
                          <td align="center" rowspan="1" colspan="1">1.55</td>
                          <td align="center" rowspan="1" colspan="1">0.009949</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">C1QBP_RAT</td>
                          <td align="center" rowspan="1" colspan="1">O35796</td>
                          <td align="center" rowspan="1" colspan="1">C1qbp</td>
                          <td align="center" rowspan="1" colspan="1">Complement component 1 Q subcomponent-binding protein, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.55</td>
                          <td align="center" rowspan="1" colspan="1">0.00327</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D4A833_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D4A833</td>
                          <td align="center" rowspan="1" colspan="1">Mrps30</td>
                          <td align="center" rowspan="1" colspan="1">Mitochondrial ribosomal protein S30</td>
                          <td align="center" rowspan="1" colspan="1">1.55</td>
                          <td align="center" rowspan="1" colspan="1">0.007282</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">DLDH_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q6P6R2</td>
                          <td align="center" rowspan="1" colspan="1">Dld</td>
                          <td align="center" rowspan="1" colspan="1">Dihydrolipoyl dehydrogenase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.55</td>
                          <td align="center" rowspan="1" colspan="1">0.005384</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0H2UI42_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0H2UI42</td>
                          <td align="center" rowspan="1" colspan="1">Mrpl30</td>
                          <td align="center" rowspan="1" colspan="1">39S ribosomal protein L30, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.54</td>
                          <td align="center" rowspan="1" colspan="1">0.00074</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">AL7A1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q64057</td>
                          <td align="center" rowspan="1" colspan="1">Aldh7a1</td>
                          <td align="center" rowspan="1" colspan="1">Alpha-aminoadipic semialdehyde dehydrogenase</td>
                          <td align="center" rowspan="1" colspan="1">1.54</td>
                          <td align="center" rowspan="1" colspan="1">0.012773</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">HMCS2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P22791</td>
                          <td align="center" rowspan="1" colspan="1">Hmgcs2</td>
                          <td align="center" rowspan="1" colspan="1">Hydroxymethylglutaryl-CoA synthase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.54</td>
                          <td align="center" rowspan="1" colspan="1">0.001604</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">DHTK1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q4KLP0</td>
                          <td align="center" rowspan="1" colspan="1">Dhtkd1</td>
                          <td align="center" rowspan="1" colspan="1">Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.54</td>
                          <td align="center" rowspan="1" colspan="1">0.001875</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">F1LM47_RAT</td>
                          <td align="center" rowspan="1" colspan="1">F1LM47</td>
                          <td align="center" rowspan="1" colspan="1">Sucla2</td>
                          <td align="center" rowspan="1" colspan="1">Succinate—CoA ligase [ADP-forming] subunit beta, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.53</td>
                          <td align="center" rowspan="1" colspan="1">0.003233</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">M0R4L6_RAT</td>
                          <td align="center" rowspan="1" colspan="1">M0R4L6</td>
                          <td align="center" rowspan="1" colspan="1">Gatb</td>
                          <td align="center" rowspan="1" colspan="1">Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.53</td>
                          <td align="center" rowspan="1" colspan="1">0.003219</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V6P2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V6P2</td>
                          <td align="center" rowspan="1" colspan="1">Dlst</td>
                          <td align="center" rowspan="1" colspan="1">Dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex), isoform CRA_a</td>
                          <td align="center" rowspan="1" colspan="1">1.53</td>
                          <td align="center" rowspan="1" colspan="1">0.015357</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JUZ5_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JUZ5</td>
                          <td align="center" rowspan="1" colspan="1">Gldc</td>
                          <td align="center" rowspan="1" colspan="1">Glycine cleavage system P protein</td>
                          <td align="center" rowspan="1" colspan="1">1.53</td>
                          <td align="center" rowspan="1" colspan="1">0.037413</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">CATB_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P00787</td>
                          <td align="center" rowspan="1" colspan="1">Ctsb</td>
                          <td align="center" rowspan="1" colspan="1">Cathepsin B</td>
                          <td align="center" rowspan="1" colspan="1">1.53</td>
                          <td align="center" rowspan="1" colspan="1">0.000854</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V6F5_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V6F5</td>
                          <td align="center" rowspan="1" colspan="1">Elac2</td>
                          <td align="center" rowspan="1" colspan="1">ElaC homolog 2 (E. coli)</td>
                          <td align="center" rowspan="1" colspan="1">1.53</td>
                          <td align="center" rowspan="1" colspan="1">0.007722</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">SDHF1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">B0K036</td>
                          <td align="center" rowspan="1" colspan="1">Sdhaf1</td>
                          <td align="center" rowspan="1" colspan="1">Succinate dehydrogenase assembly factor 1, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.53</td>
                          <td align="center" rowspan="1" colspan="1">0.016151</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">RM38_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q5PQN9</td>
                          <td align="center" rowspan="1" colspan="1">Mrpl38</td>
                          <td align="center" rowspan="1" colspan="1">39S ribosomal protein L38, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.53</td>
                          <td align="center" rowspan="1" colspan="1">0.018071</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D3ZDX7_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D3ZDX7</td>
                          <td align="center" rowspan="1" colspan="1">Mrpl48</td>
                          <td align="center" rowspan="1" colspan="1">Mitochondrial ribosomal protein L48</td>
                          <td align="center" rowspan="1" colspan="1">1.53</td>
                          <td align="center" rowspan="1" colspan="1">0.007002</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2K7D7_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2K7D7</td>
                          <td align="center" rowspan="1" colspan="1">Nars2</td>
                          <td align="center" rowspan="1" colspan="1">Asparaginyl-tRNA synthetase 2, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.52</td>
                          <td align="center" rowspan="1" colspan="1">0.002014</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V879_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V879</td>
                          <td align="center" rowspan="1" colspan="1">Coq7</td>
                          <td align="center" rowspan="1" colspan="1">5-demethoxyubiquinone hydroxylase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.52</td>
                          <td align="center" rowspan="1" colspan="1">0.010989</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">ETFB_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q68FU3</td>
                          <td align="center" rowspan="1" colspan="1">Etfb</td>
                          <td align="center" rowspan="1" colspan="1">Electron transfer flavoprotein subunit beta</td>
                          <td align="center" rowspan="1" colspan="1">1.52</td>
                          <td align="center" rowspan="1" colspan="1">0.003036</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D3ZDP2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D3ZDP2</td>
                          <td align="center" rowspan="1" colspan="1">Mrpl58</td>
                          <td align="center" rowspan="1" colspan="1">Mitochondrial ribosomal protein L58</td>
                          <td align="center" rowspan="1" colspan="1">1.52</td>
                          <td align="center" rowspan="1" colspan="1">0.01954</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V8W9_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V8W9</td>
                          <td align="center" rowspan="1" colspan="1">Tstd3</td>
                          <td align="center" rowspan="1" colspan="1">Similar to CG12279-PA</td>
                          <td align="center" rowspan="1" colspan="1">1.52</td>
                          <td align="center" rowspan="1" colspan="1">0.000938</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D4AB01_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D4AB01</td>
                          <td align="center" rowspan="1" colspan="1">Hint2</td>
                          <td align="center" rowspan="1" colspan="1">Histidine triad nucleotide binding protein 2 (Predicted), isoform CRA_a</td>
                          <td align="center" rowspan="1" colspan="1">1.52</td>
                          <td align="center" rowspan="1" colspan="1">0.002216</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">CH60_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P63039</td>
                          <td align="center" rowspan="1" colspan="1">Hspd1</td>
                          <td align="center" rowspan="1" colspan="1">60 kDa heat shock protein, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.52</td>
                          <td align="center" rowspan="1" colspan="1">0.004245</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D3ZUI9_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D3ZUI9</td>
                          <td align="center" rowspan="1" colspan="1">Ndufaf8</td>
                          <td align="center" rowspan="1" colspan="1">NADH:ubiquinone oxidoreductase complex assembly factor 8</td>
                          <td align="center" rowspan="1" colspan="1">1.52</td>
                          <td align="center" rowspan="1" colspan="1">0.002759</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D3ZT90_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D3ZT90</td>
                          <td align="center" rowspan="1" colspan="1">Gcdh</td>
                          <td align="center" rowspan="1" colspan="1">Glutaryl-CoA dehydrogenase</td>
                          <td align="center" rowspan="1" colspan="1">1.52</td>
                          <td align="center" rowspan="1" colspan="1">0.035278</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">TM10C_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q5U2R4</td>
                          <td align="center" rowspan="1" colspan="1">Trmt10c</td>
                          <td align="center" rowspan="1" colspan="1">tRNA methyltransferase 10 homolog C</td>
                          <td align="center" rowspan="1" colspan="1">1.52</td>
                          <td align="center" rowspan="1" colspan="1">0.004136</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JW34_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JW34</td>
                          <td align="center" rowspan="1" colspan="1">Cisd3</td>
                          <td align="center" rowspan="1" colspan="1">CDGSH iron sulfur domain 3</td>
                          <td align="center" rowspan="1" colspan="1">1.52</td>
                          <td align="center" rowspan="1" colspan="1">0.013893</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D3ZZR9_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D3ZZR9</td>
                          <td align="center" rowspan="1" colspan="1">Fkbp2</td>
                          <td align="center" rowspan="1" colspan="1">Peptidylprolyl isomerase</td>
                          <td align="center" rowspan="1" colspan="1">1.51</td>
                          <td align="center" rowspan="1" colspan="1">0.006559</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">ACSF2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q499N5</td>
                          <td align="center" rowspan="1" colspan="1">Acsf2</td>
                          <td align="center" rowspan="1" colspan="1">Acyl-CoA synthetase family member 2, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.51</td>
                          <td align="center" rowspan="1" colspan="1">0.004325</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D3ZJY1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D3ZJY1</td>
                          <td align="center" rowspan="1" colspan="1">Mrpl28</td>
                          <td align="center" rowspan="1" colspan="1">Mitochondrial ribosomal protein L28</td>
                          <td align="center" rowspan="1" colspan="1">1.51</td>
                          <td align="center" rowspan="1" colspan="1">0.012429</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">PREY_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q5U1Z8</td>
                          <td align="center" rowspan="1" colspan="1">Pyurf</td>
                          <td align="center" rowspan="1" colspan="1">Protein preY, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.51</td>
                          <td align="center" rowspan="1" colspan="1">0.02374</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">M0RAK2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">M0RAK2</td>
                          <td align="center" rowspan="1" colspan="1">LOC684270</td>
                          <td align="center" rowspan="1" colspan="1">RCG22622</td>
                          <td align="center" rowspan="1" colspan="1">1.51</td>
                          <td align="center" rowspan="1" colspan="1">0.000417</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">RM10_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P0C2C4</td>
                          <td align="center" rowspan="1" colspan="1">Mrpl10</td>
                          <td align="center" rowspan="1" colspan="1">39S ribosomal protein L10, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.51</td>
                          <td align="center" rowspan="1" colspan="1">0.002504</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">Q3MHT2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q3MHT2</td>
                          <td align="center" rowspan="1" colspan="1">Nfs1</td>
                          <td align="center" rowspan="1" colspan="1">Cysteine desulfurase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.51</td>
                          <td align="center" rowspan="1" colspan="1">0.0099</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">SYDM_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q3KRD0</td>
                          <td align="center" rowspan="1" colspan="1">Dars2</td>
                          <td align="center" rowspan="1" colspan="1">Aspartate—tRNA ligase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.51</td>
                          <td align="center" rowspan="1" colspan="1">0.009136</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">COQ6_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q68FU7</td>
                          <td align="center" rowspan="1" colspan="1">Coq6</td>
                          <td align="center" rowspan="1" colspan="1">Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.51</td>
                          <td align="center" rowspan="1" colspan="1">0.003601</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">COX5B_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P12075</td>
                          <td align="center" rowspan="1" colspan="1">Cox5b</td>
                          <td align="center" rowspan="1" colspan="1">Cytochrome c oxidase subunit 5B, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.51</td>
                          <td align="center" rowspan="1" colspan="1">0.034268</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V828_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V828</td>
                          <td align="center" rowspan="1" colspan="1">Cnpy3</td>
                          <td align="center" rowspan="1" colspan="1">Canopy FGF-signaling regulator 3</td>
                          <td align="center" rowspan="1" colspan="1">1.50</td>
                          <td align="center" rowspan="1" colspan="1">0.011124</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">M0R7R2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">M0R7R2</td>
                          <td align="center" rowspan="1" colspan="1">LOC683897</td>
                          <td align="center" rowspan="1" colspan="1">Similar to Protein C6orf203</td>
                          <td align="center" rowspan="1" colspan="1">1.50</td>
                          <td align="center" rowspan="1" colspan="1">0.008352</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">FRDA_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D3ZYW7</td>
                          <td align="center" rowspan="1" colspan="1">Fxn</td>
                          <td align="center" rowspan="1" colspan="1">Frataxin, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.50</td>
                          <td align="center" rowspan="1" colspan="1">0.005993</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JTL5_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JTL5</td>
                          <td align="center" rowspan="1" colspan="1">Pc</td>
                          <td align="center" rowspan="1" colspan="1">Pyruvate carboxylase, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.50</td>
                          <td align="center" rowspan="1" colspan="1">0.007181</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">F1LM33_RAT</td>
                          <td align="center" rowspan="1" colspan="1">F1LM33</td>
                          <td align="center" rowspan="1" colspan="1">Lrpprc</td>
                          <td align="center" rowspan="1" colspan="1">Leucine-rich PPR motif-containing protein, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.50</td>
                          <td align="center" rowspan="1" colspan="1">0.002213</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0A0MXZ0_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0A0MXZ0</td>
                          <td align="center" rowspan="1" colspan="1">Isca1</td>
                          <td align="center" rowspan="1" colspan="1">Iron-sulfur cluster assembly 1 homolog, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.50</td>
                          <td align="center" rowspan="1" colspan="1">0.026833</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">IDHG1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P41565</td>
                          <td align="center" rowspan="1" colspan="1">Idh3g</td>
                          <td align="center" rowspan="1" colspan="1">Isocitrate dehydrogenase [NAD] subunit gamma 1, mitochondrial</td>
                          <td align="center" rowspan="1" colspan="1">1.50</td>
                          <td align="center" rowspan="1" colspan="1">0.002832</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">SYGP1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q9QUH6</td>
                          <td align="center" rowspan="1" colspan="1">Syngap1</td>
                          <td align="center" rowspan="1" colspan="1">Ras/Rap GTPase-activating protein SynGAP</td>
                          <td align="center" rowspan="1" colspan="1">0.67</td>
                          <td align="center" rowspan="1" colspan="1">0.004016</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JZB8_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JZB8</td>
                          <td align="center" rowspan="1" colspan="1">Gpm6b</td>
                          <td align="center" rowspan="1" colspan="1">Neuronal membrane glycoprotein M6-b</td>
                          <td align="center" rowspan="1" colspan="1">0.66</td>
                          <td align="center" rowspan="1" colspan="1">0.006135</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">TBB2B_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q3KRE8</td>
                          <td align="center" rowspan="1" colspan="1">Tubb2b</td>
                          <td align="center" rowspan="1" colspan="1">Tubulin beta-2B chain</td>
                          <td align="center" rowspan="1" colspan="1">0.66</td>
                          <td align="center" rowspan="1" colspan="1">0.010335</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D4A1J3_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D4A1J3</td>
                          <td align="center" rowspan="1" colspan="1">Palm3</td>
                          <td align="center" rowspan="1" colspan="1">Paralemmin 3</td>
                          <td align="center" rowspan="1" colspan="1">0.66</td>
                          <td align="center" rowspan="1" colspan="1">0.012666</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">LDHA_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P04642</td>
                          <td align="center" rowspan="1" colspan="1">Ldha</td>
                          <td align="center" rowspan="1" colspan="1">L-lactate dehydrogenase A chain</td>
                          <td align="center" rowspan="1" colspan="1">0.66</td>
                          <td align="center" rowspan="1" colspan="1">0.001603</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A096MJW6_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A096MJW6</td>
                          <td align="center" rowspan="1" colspan="1">Il1rapl1</td>
                          <td align="center" rowspan="1" colspan="1">Interleukin-1 receptor accessory protein-like 1</td>
                          <td align="center" rowspan="1" colspan="1">0.66</td>
                          <td align="center" rowspan="1" colspan="1">0.021052</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2K0M8_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2K0M8</td>
                          <td align="center" rowspan="1" colspan="1">Ncam1</td>
                          <td align="center" rowspan="1" colspan="1">Neural cell adhesion molecule 1</td>
                          <td align="center" rowspan="1" colspan="1">0.66</td>
                          <td align="center" rowspan="1" colspan="1">0.00849</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">CLCB_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P08082</td>
                          <td align="center" rowspan="1" colspan="1">Cltb</td>
                          <td align="center" rowspan="1" colspan="1">Clathrin light chain B</td>
                          <td align="center" rowspan="1" colspan="1">0.66</td>
                          <td align="center" rowspan="1" colspan="1">0.005589</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">F1LR33_RAT</td>
                          <td align="center" rowspan="1" colspan="1">F1LR33</td>
                          <td align="center" rowspan="1" colspan="1">Plppr2</td>
                          <td align="center" rowspan="1" colspan="1">Phospholipid phosphatase-related protein type 2</td>
                          <td align="center" rowspan="1" colspan="1">0.66</td>
                          <td align="center" rowspan="1" colspan="1">0.011704</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">PALM_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q920Q0</td>
                          <td align="center" rowspan="1" colspan="1">Palm</td>
                          <td align="center" rowspan="1" colspan="1">Paralemmin-1</td>
                          <td align="center" rowspan="1" colspan="1">0.66</td>
                          <td align="center" rowspan="1" colspan="1">0.007084</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">F1MA89_RAT</td>
                          <td align="center" rowspan="1" colspan="1">F1MA89</td>
                          <td align="center" rowspan="1" colspan="1">Ccny</td>
                          <td align="center" rowspan="1" colspan="1">Cyclin Y</td>
                          <td align="center" rowspan="1" colspan="1">0.65</td>
                          <td align="center" rowspan="1" colspan="1">0.005391</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">SV2B_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q63564</td>
                          <td align="center" rowspan="1" colspan="1">Sv2b</td>
                          <td align="center" rowspan="1" colspan="1">Synaptic vesicle glycoprotein 2B</td>
                          <td align="center" rowspan="1" colspan="1">0.65</td>
                          <td align="center" rowspan="1" colspan="1">0.009948</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">SC6A1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P23978</td>
                          <td align="center" rowspan="1" colspan="1">Slc6a1</td>
                          <td align="center" rowspan="1" colspan="1">Sodium- and chloride-dependent GABA transporter 1</td>
                          <td align="center" rowspan="1" colspan="1">0.65</td>
                          <td align="center" rowspan="1" colspan="1">0.002724</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">FGF14_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q8R5L7</td>
                          <td align="center" rowspan="1" colspan="1">Fgf14</td>
                          <td align="center" rowspan="1" colspan="1">Fibroblast growth factor 14</td>
                          <td align="center" rowspan="1" colspan="1">0.65</td>
                          <td align="center" rowspan="1" colspan="1">0.017128</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">Q4V7D9_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q4V7D9</td>
                          <td align="center" rowspan="1" colspan="1">Smpdl3b</td>
                          <td align="center" rowspan="1" colspan="1">Acid sphingomyelinase-like phosphodiesterase</td>
                          <td align="center" rowspan="1" colspan="1">0.65</td>
                          <td align="center" rowspan="1" colspan="1">0.009225</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V7A9_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V7A9</td>
                          <td align="center" rowspan="1" colspan="1">Cldn10</td>
                          <td align="center" rowspan="1" colspan="1">Claudin</td>
                          <td align="center" rowspan="1" colspan="1">0.65</td>
                          <td align="center" rowspan="1" colspan="1">0.011512</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">SCN2B_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P54900</td>
                          <td align="center" rowspan="1" colspan="1">Scn2b</td>
                          <td align="center" rowspan="1" colspan="1">Sodium channel subunit beta-2</td>
                          <td align="center" rowspan="1" colspan="1">0.65</td>
                          <td align="center" rowspan="1" colspan="1">0.001306</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">D4AA77_RAT</td>
                          <td align="center" rowspan="1" colspan="1">D4AA77</td>
                          <td align="center" rowspan="1" colspan="1">Plxnd1</td>
                          <td align="center" rowspan="1" colspan="1">Plexin D1</td>
                          <td align="center" rowspan="1" colspan="1">0.64</td>
                          <td align="center" rowspan="1" colspan="1">0.018219</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JVB0_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JVB0</td>
                          <td align="center" rowspan="1" colspan="1">Slc2a3</td>
                          <td align="center" rowspan="1" colspan="1">Solute carrier family 2, facilitated glucose transporter member 3-like</td>
                          <td align="center" rowspan="1" colspan="1">0.63</td>
                          <td align="center" rowspan="1" colspan="1">0.005762</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">HBA_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P01946</td>
                          <td align="center" rowspan="1" colspan="1">Hba1</td>
                          <td align="center" rowspan="1" colspan="1">Hemoglobin subunit alpha-1/2</td>
                          <td align="center" rowspan="1" colspan="1">0.63</td>
                          <td align="center" rowspan="1" colspan="1">0.001886</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">ENOB_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P15429</td>
                          <td align="center" rowspan="1" colspan="1">Eno3</td>
                          <td align="center" rowspan="1" colspan="1">Beta-enolase</td>
                          <td align="center" rowspan="1" colspan="1">0.63</td>
                          <td align="center" rowspan="1" colspan="1">0.025177</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GRID1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q62640</td>
                          <td align="center" rowspan="1" colspan="1">Grid1</td>
                          <td align="center" rowspan="1" colspan="1">Glutamate receptor ionotropic, delta-1</td>
                          <td align="center" rowspan="1" colspan="1">0.63</td>
                          <td align="center" rowspan="1" colspan="1">0.002788</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">F1M7N2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">F1M7N2</td>
                          <td align="center" rowspan="1" colspan="1">Entpd2</td>
                          <td align="center" rowspan="1" colspan="1">Ectonucleoside triphosphate diphosphohydrolase 2</td>
                          <td align="center" rowspan="1" colspan="1">0.63</td>
                          <td align="center" rowspan="1" colspan="1">0.00134</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">ALBU_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P02770</td>
                          <td align="center" rowspan="1" colspan="1">Alb</td>
                          <td align="center" rowspan="1" colspan="1">Serum albumin</td>
                          <td align="center" rowspan="1" colspan="1">0.62</td>
                          <td align="center" rowspan="1" colspan="1">0.001197</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">Q499T3_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q499T3</td>
                          <td align="center" rowspan="1" colspan="1">Sirpa</td>
                          <td align="center" rowspan="1" colspan="1">Sirpa protein</td>
                          <td align="center" rowspan="1" colspan="1">0.62</td>
                          <td align="center" rowspan="1" colspan="1">0.008158</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">2ABG_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P97888</td>
                          <td align="center" rowspan="1" colspan="1">Ppp2r2c</td>
                          <td align="center" rowspan="1" colspan="1">Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform</td>
                          <td align="center" rowspan="1" colspan="1">0.62</td>
                          <td align="center" rowspan="1" colspan="1">0.027676</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JTH4_RAT</td>
                          <td align="center" rowspan="1" colspan="1">A0A0G2JTH4</td>
                          <td align="center" rowspan="1" colspan="1">Cd47</td>
                          <td align="center" rowspan="1" colspan="1">Leukocyte surface antigen CD47</td>
                          <td align="center" rowspan="1" colspan="1">0.61</td>
                          <td align="center" rowspan="1" colspan="1">0.011316</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">M0RBJ0_RAT</td>
                          <td align="center" rowspan="1" colspan="1">M0RBJ0</td>
                          <td align="center" rowspan="1" colspan="1">Gng2</td>
                          <td align="center" rowspan="1" colspan="1">Guanine nucleotide-binding protein subunit gamma</td>
                          <td align="center" rowspan="1" colspan="1">0.61</td>
                          <td align="center" rowspan="1" colspan="1">0.003203</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">G3V6R0_RAT</td>
                          <td align="center" rowspan="1" colspan="1">G3V6R0</td>
                          <td align="center" rowspan="1" colspan="1">Slc1a2</td>
                          <td align="center" rowspan="1" colspan="1">Amino acid transporter</td>
                          <td align="center" rowspan="1" colspan="1">0.61</td>
                          <td align="center" rowspan="1" colspan="1">0.008327</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">CRYM_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q9QYU4</td>
                          <td align="center" rowspan="1" colspan="1">Crym</td>
                          <td align="center" rowspan="1" colspan="1">Ketimine reductase mu-crystallin</td>
                          <td align="center" rowspan="1" colspan="1">0.61</td>
                          <td align="center" rowspan="1" colspan="1">0.010508</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">NRN1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">O08957</td>
                          <td align="center" rowspan="1" colspan="1">Nrn1</td>
                          <td align="center" rowspan="1" colspan="1">Neuritin</td>
                          <td align="center" rowspan="1" colspan="1">0.60</td>
                          <td align="center" rowspan="1" colspan="1">0.003871</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GPM6A_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q812E9</td>
                          <td align="center" rowspan="1" colspan="1">Gpm6a</td>
                          <td align="center" rowspan="1" colspan="1">Neuronal membrane glycoprotein M6-a</td>
                          <td align="center" rowspan="1" colspan="1">0.58</td>
                          <td align="center" rowspan="1" colspan="1">0.005952</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">KCIP2_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q9JM59</td>
                          <td align="center" rowspan="1" colspan="1">Kcnip2</td>
                          <td align="center" rowspan="1" colspan="1">Kv channel-interacting protein 2</td>
                          <td align="center" rowspan="1" colspan="1">0.55</td>
                          <td align="center" rowspan="1" colspan="1">0.013844</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">F1M9G9_RAT</td>
                          <td align="center" rowspan="1" colspan="1">F1M9G9</td>
                          <td align="center" rowspan="1" colspan="1">Scn2a</td>
                          <td align="center" rowspan="1" colspan="1">Sodium channel protein</td>
                          <td align="center" rowspan="1" colspan="1">0.51</td>
                          <td align="center" rowspan="1" colspan="1">0.008815</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">E9PSV8_RAT</td>
                          <td align="center" rowspan="1" colspan="1">E9PSV8</td>
                          <td align="center" rowspan="1" colspan="1">Gpm6b</td>
                          <td align="center" rowspan="1" colspan="1">Neuronal membrane glycoprotein M6-b</td>
                          <td align="center" rowspan="1" colspan="1">0.45</td>
                          <td align="center" rowspan="1" colspan="1">0.034939</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
              </sec>
              <sec id="sec017">
                <title>Bioinformatics analysis of DEPs in mitochondrial proteome</title>
                <p>In order to have a functional overview of the DEPs, we performed function annotation by GO and KEGG analyses. The most relevant and significant enriched terms and pathways (FDR&lt;0.01) were illustrated by biological process (BP) (<xref rid="pone.0265108.t002" ref-type="table">Table 2</xref>), cellular compartment (CC) (<xref rid="pone.0265108.t003" ref-type="table">Table 3</xref>), molecular function (MF) (<xref rid="pone.0265108.t004" ref-type="table">Table 4</xref>), and KEGG pathway (<xref rid="pone.0265108.t005" ref-type="table">Table 5</xref>) separately. The GO and KEGG Term ID, Term, Rich factors (Ratio), Enrichment, FDR and Protein IDs included were all listed in these tables. The most significantly enriched GO terms in the biological process category were mainly annotated with the terms tricarboxylic acid (TCA) cycle (GO: 0006099, 13 proteins), fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO: 0033539, 7 proteins), 2-oxoglutarate metabolic process (GO: 0006103, 5 proteins), etc. DEPs classified in the cellular component category were mainly annotated with the terms mitochondrion (GO: 0005739, 75 proteins) and mitochondrial matrix (GO: 0005759, 28 proteins). DEPs classified in the molecular function category were mainly annotated with the terms flavin adenine dinucleotide binding (GO: 0050660, 8 proteins), pyridoxal phosphate binding (GO: 0030170, 8 proteins), NAD binding (GO: 0051287, 8 proteins) and Succinate-CoA ligase (ADP-forming) activity (GO: 0004775, 3 proteins). The 163 DEPs were annotated with KEGG pathways, and the top 3 most enriched pathways were carbon metabolism (path: rno01200, 19 proteins), valine, leucine and isoleucine degradation (path: rno00280, 12 proteins) and metabolic pathways (path: rno01100, 40 proteins), and the citrate cycle (TCA cycle) was one of the significantly enriched metabolic pathways.</p>
                <table-wrap position="float" id="pone.0265108.t002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0265108.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>The significantly enriched GO terms related to biological processes.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0265108.t002" id="pone.0265108.t002g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">Term ID</th>
                          <th align="center" rowspan="1" colspan="1">Term</th>
                          <th align="center" rowspan="1" colspan="1">Ratio</th>
                          <th align="center" rowspan="1" colspan="1">Enrichment</th>
                          <th align="center" rowspan="1" colspan="1">FDR</th>
                          <th align="center" rowspan="1" colspan="1">Protein IDs</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GO:0006099</td>
                          <td align="center" rowspan="1" colspan="1">tricarboxylic acid cycle</td>
                          <td align="center" rowspan="1" colspan="1">0.52</td>
                          <td align="center" rowspan="1" colspan="1">12.10</td>
                          <td align="center" rowspan="1" colspan="1">4.40E-10</td>
                          <td align="left" rowspan="1" colspan="1">ACON_RAT,MDHM_RAT,F1LM47_RAT,F1LNF7_RAT,IDH3B_RAT,FUMH_RAT,IDHG1_RAT,G3V6P2_RAT,IDHP_RAT,G3V936_RAT,A0A0H2UHE1_RAT,F1LPV8_RAT,DHTK1_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GO:0033539</td>
                          <td align="center" rowspan="1" colspan="1">fatty acid beta-oxidation using acyl-CoA dehydrogenase</td>
                          <td align="center" rowspan="1" colspan="1">0.78</td>
                          <td align="center" rowspan="1" colspan="1">8.44</td>
                          <td align="center" rowspan="1" colspan="1">1.01E-06</td>
                          <td align="left" rowspan="1" colspan="1">ETFA_RAT,IVD_RAT,ACADL_RAT,ETFB_RAT,D3ZT90_RAT,G3V796_RAT,Q6IMX3_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GO:0006103</td>
                          <td align="center" rowspan="1" colspan="1">2-oxoglutarate metabolic process</td>
                          <td align="center" rowspan="1" colspan="1">0.63</td>
                          <td align="center" rowspan="1" colspan="1">5.40</td>
                          <td align="center" rowspan="1" colspan="1">0.000742</td>
                          <td align="left" rowspan="1" colspan="1">AATM_RAT,DLDH_RAT,IDH3B_RAT,IDHG1_RAT,IDHP_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GO:0006102</td>
                          <td align="center" rowspan="1" colspan="1">isocitrate metabolic process</td>
                          <td align="center" rowspan="1" colspan="1">0.80</td>
                          <td align="center" rowspan="1" colspan="1">4.99</td>
                          <td align="center" rowspan="1" colspan="1">0.001418</td>
                          <td align="left" rowspan="1" colspan="1">ACON_RAT,IDH3B_RAT,IDHG1_RAT,IDHP_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GO:0019254</td>
                          <td align="center" rowspan="1" colspan="1">carnitine metabolic process, CoA-linked</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">4.25</td>
                          <td align="center" rowspan="1" colspan="1">0.006217</td>
                          <td align="left" rowspan="1" colspan="1">ACADL_RAT,A0A0H2UI21_RAT,G3V796_RAT</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <table-wrap position="float" id="pone.0265108.t003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0265108.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>The significantly enriched GO terms related to cellular component.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0265108.t003" id="pone.0265108.t003g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">Term ID</th>
                          <th align="center" rowspan="1" colspan="1">Term</th>
                          <th align="center" rowspan="1" colspan="1">Ratio</th>
                          <th align="center" rowspan="1" colspan="1">Enrichment</th>
                          <th align="center" rowspan="1" colspan="1">FDR</th>
                          <th align="center" rowspan="1" colspan="1">Protein IDs</th>
                          <th align="center" rowspan="1" colspan="1">Accession</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GO:0005739</td>
                          <td align="center" rowspan="1" colspan="1">mitochondrion</td>
                          <td align="center" rowspan="1" colspan="1">0.16</td>
                          <td align="center" rowspan="1" colspan="1">30.24</td>
                          <td align="center" rowspan="1" colspan="1">7.92E-29</td>
                          <td align="left" rowspan="1" colspan="1">ACON_RAT,CH60_RAT,DHE3_RAT,A0A0G2JTL5_RAT,GABT_RAT,MDHM_RAT,AATM_RAT,THIL_RAT,DLDH_RAT,F1LM47_RAT,F1LNF7_RAT,G3V945_RAT,FUMH_RAT,IDHG1_RAT,SCOT1_RAT,G3V7J0_RAT,A0A0G2JSS8_RAT,G3V6P2_RAT,F1M5N4_RAT,IDHP_RAT,A0A0H2UHE1_RAT,G3V7I5_RAT,ETFA_RAT,AL7A1_RAT,IVD_RAT,ACSF2_RAT,ES1_RAT,3HIDH_RAT,AUHM_RAT,ACADL_RAT,G3V9U2_RAT,OAT_RAT,A0A0H2UI21_RAT,ECHM_RAT,F1LPV8_RAT,C1QBP_RAT,SODM_RAT,CH10_RAT,D4AB01_RAT,Q5U3Z7_RAT,ATIF1_RAT,MAAI_RAT,G3V7I0_RAT,ECH1_RAT,TRXR2_RAT,A0A0G2JUZ5_RAT,CATB_RAT,PPIF_RAT,DHTK1_RAT,D4ADD7_RAT,COQ6_RAT,FAHD1_RAT,GCSH_RAT,GATA_RAT,D3ZT90_RAT,G3V796_RAT,TM10C_RAT,HMCS2_RAT,D4A833_RAT,Q6IMX3_RAT,Q6AY99_RAT,D3ZUI9_RAT,F1M8H2_RAT,D3ZT98_RAT,PREY_RAT,FMT_RAT,FRDA_RAT,HOT_RAT,A0A0G2K2Q2_RAT,A0A0G2K7D7_RAT,M0R4L6_RAT,A0A0G2K9G3_RAT,F210A_RAT,G3V8U8_RAT,SDHF1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">Q9ER34,P63039,P10860,A0A0G2JTL5,P50554,P04636,P00507,P17764,Q6P6R2,F1LM47,F1LNF7,G3V945,P14408,P41565,B2GV06,G3V7J0,A0A0G2JSS8,G3V6P2,F1M5N4,P56574,A0A0H2UHE1,G3V7I5,P13803,Q64057,P12007,Q499N5,P56571,P29266,F1LU71,P15650,G3V9U2,P04182,A0A0H2UI21,P14604,F1LPV8,O35796,P07895,P26772,D4AB01,Q5U3Z7,Q03344,P57113,G3V7I0,Q62651,Q9Z0J5,A0A0G2JUZ5,P00787,P29117,Q4KLP0,D4ADD7,Q68FU7,Q6AYQ8,Q5I0P2,Q5FWT5,D3ZT90,G3V796,Q5U2R4,P22791,D4A833,Q6IMX3,Q6AY99,D3ZUI9,F1M8H2,D3ZT98,Q5U1Z8,Q5I0C5,D3ZYW7,Q4QQW3,A0A0G2K2Q2,A0A0G2K7D7,M0R4L6,A0A0G2K9G3,Q5XIJ4,G3V8U8,B0K036</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GO:0005759</td>
                          <td align="center" rowspan="1" colspan="1">mitochondrial matrix</td>
                          <td align="center" rowspan="1" colspan="1">0.33</td>
                          <td align="center" rowspan="1" colspan="1">18.83</td>
                          <td align="center" rowspan="1" colspan="1">1.02E-17</td>
                          <td align="left" rowspan="1" colspan="1">CH60_RAT,DHE3_RAT,GABT_RAT,MDHM_RAT,AATM_RAT,THIL_RAT,DLDH_RAT,SCOT1_RAT,G3V936_RAT,ETFA_RAT,IVD_RAT,ACADL_RAT,OAT_RAT,ETFB_RAT,ECHM_RAT,C1QBP_RAT,CH10_RAT,THTR_RAT,Q5U3Z7_RAT,F1LP30_RAT,A0A0G2JZA2_RAT,PPIF_RAT,D4ADD7_RAT,HMCS2_RAT,SYDM_RAT,F1M8H2_RAT,D4A7X5_RAT,SDHF1_RAT</td>
                          <td align="center" rowspan="1" colspan="1">P63039,P10860,P50554,P04636,P00507,P17764,Q6P6R2,B2GV06,G3V936,P13803,P12007,P15650,P04182,Q68FU3,P14604,O35796,P26772,P24329,Q5U3Z7,F1LP30,A0A0G2JZA2,P29117,D4ADD7,P22791,Q3KRD0,F1M8H2,D4A7X5,B0K036</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <table-wrap position="float" id="pone.0265108.t004">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0265108.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>The significantly enriched GO terms related to molecular function.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0265108.t004" id="pone.0265108.t004g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">Term ID</th>
                          <th align="center" rowspan="1" colspan="1">Term</th>
                          <th align="justify" rowspan="1" colspan="1">Ratio</th>
                          <th align="center" rowspan="1" colspan="1">Enrichment</th>
                          <th align="center" rowspan="1" colspan="1">FDR</th>
                          <th align="center" rowspan="1" colspan="1">Protein IDs</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GO:0050660</td>
                          <td align="center" rowspan="1" colspan="1">flavin adenine dinucleotide binding</td>
                          <td align="center" rowspan="1" colspan="1">0.35</td>
                          <td align="center" rowspan="1" colspan="1">5.70</td>
                          <td align="center" rowspan="1" colspan="1">0.000539659</td>
                          <td align="left" rowspan="1" colspan="1">DLDH_RAT,ETFA_RAT,IVD_RAT,ACADL_RAT,TRXR2_RAT,D3ZT90_RAT,G3V796_RAT,Q6IMX3_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GO:0030170</td>
                          <td align="center" rowspan="1" colspan="1">pyridoxal phosphate binding</td>
                          <td align="center" rowspan="1" colspan="1">0.30</td>
                          <td align="center" rowspan="1" colspan="1">5.11</td>
                          <td align="center" rowspan="1" colspan="1">0.00106165</td>
                          <td align="left" rowspan="1" colspan="1">GABT_RAT,AATM_RAT,ALBU_RAT,OAT_RAT,Q5U3Z7_RAT,Q3MHT2_RAT,A0A0G2JUZ5_RAT,A0A0G2K2Q2_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GO:0051287</td>
                          <td align="center" rowspan="1" colspan="1">NAD binding</td>
                          <td align="center" rowspan="1" colspan="1">0.26</td>
                          <td align="center" rowspan="1" colspan="1">4.62</td>
                          <td align="center" rowspan="1" colspan="1">0.002185681</td>
                          <td align="left" rowspan="1" colspan="1">DLDH_RAT,F1LNF7_RAT,IDH3B_RAT,IDHG1_RAT,F1M5N4_RAT,IDHP_RAT,3HIDH_RAT,LDHA_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">GO:0004775</td>
                          <td align="center" rowspan="1" colspan="1">succinate-CoA ligase (ADP-forming) activity</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1">4.16</td>
                          <td align="center" rowspan="1" colspan="1">0.004661018</td>
                          <td align="left" rowspan="1" colspan="1">F1LM47_RAT,A0A0H2UHE1_RAT,F1LPV8_RAT</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <table-wrap position="float" id="pone.0265108.t005">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0265108.t005</object-id>
                  <label>Table 5</label>
                  <caption>
                    <title>The significantly enriched KEGG pathway from the DEPs.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0265108.t005" id="pone.0265108.t005g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">Term ID</th>
                          <th align="center" rowspan="1" colspan="1">Term</th>
                          <th align="justify" rowspan="1" colspan="1">Ratio</th>
                          <th align="left" rowspan="1" colspan="1">Enrichment</th>
                          <th align="center" rowspan="1" colspan="1">FDR</th>
                          <th align="center" rowspan="1" colspan="1">Protein IDs</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno01200</td>
                          <td align="center" rowspan="1" colspan="1">Carbon metabolism</td>
                          <td align="center" rowspan="1" colspan="1">0.33</td>
                          <td align="center" rowspan="1" colspan="1">12.58</td>
                          <td align="center" rowspan="1" colspan="1">2.92E-11</td>
                          <td align="left" rowspan="1" colspan="1">ACON_RAT,DHE3_RAT,MDHM_RAT,AATM_RAT,THIL_RAT,DLDH_RAT,F1LM47_RAT,IDH3B_RAT,G3V7J0_RAT,G3V6P2_RAT,F1M5N4_RAT,IDHP_RAT,Q68FZ8_RAT,ECHM_RAT,ENOB_RAT,Q5U3Z7_RAT,GCSH_RAT,G3V796_RAT,Q6IMX3_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno00280</td>
                          <td align="center" rowspan="1" colspan="1">Valine, leucine and isoleucine degradation</td>
                          <td align="center" rowspan="1" colspan="1">0.46</td>
                          <td align="center" rowspan="1" colspan="1">9.86</td>
                          <td align="center" rowspan="1" colspan="1">7.66E-09</td>
                          <td align="left" rowspan="1" colspan="1">GABT_RAT,THIL_RAT,DLDH_RAT,SCOT1_RAT,G3V7J0_RAT,Q68FZ8_RAT,AL7A1_RAT,IVD_RAT,3HIDH_RAT,ECHM_RAT,G3V796_RAT,Q6IMX3_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno01100</td>
                          <td align="center" rowspan="1" colspan="1">Metabolic pathways</td>
                          <td align="center" rowspan="1" colspan="1">0.11</td>
                          <td align="center" rowspan="1" colspan="1">9.49</td>
                          <td align="center" rowspan="1" colspan="1">1.19E-08</td>
                          <td align="left" rowspan="1" colspan="1">ACON_RAT,DHE3_RAT,GABT_RAT,MDHM_RAT,AATM_RAT,THIL_RAT,DLDH_RAT,F1LM47_RAT,G3V945_RAT,IDH3B_RAT,G3V7J0_RAT,G3V6P2_RAT,F1M5N4_RAT,IDHP_RAT,Q68FZ8_RAT,AL7A1_RAT,IVD_RAT,3HIDH_RAT,ACADL_RAT,OAT_RAT,LDHA_RAT,ECHM_RAT,COX5B_RAT,ENOB_RAT,THTR_RAT,Q5U3Z7_RAT,Q3MHT2_RAT,MAAI_RAT,DHTK1_RAT,COQ6_RAT,FAHD1_RAT,GCSH_RAT,GATA_RAT,D3ZT90_RAT,G3V796_RAT,Q6IMX3_RAT,Q6AY99_RAT,M0R4L6_RAT,CEGT_RAT,ATP6_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno00640</td>
                          <td align="center" rowspan="1" colspan="1">Propanoate metabolism</td>
                          <td align="center" rowspan="1" colspan="1">0.50</td>
                          <td align="center" rowspan="1" colspan="1">7.83</td>
                          <td align="center" rowspan="1" colspan="1">4.13E-07</td>
                          <td align="left" rowspan="1" colspan="1">GABT_RAT,THIL_RAT,DLDH_RAT,F1LM47_RAT,G3V7J0_RAT,Q68FZ8_RAT,LDHA_RAT,ECHM_RAT,G3V796_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno00310</td>
                          <td align="center" rowspan="1" colspan="1">Lysine degradation</td>
                          <td align="center" rowspan="1" colspan="1">0.47</td>
                          <td align="center" rowspan="1" colspan="1">5.89</td>
                          <td align="center" rowspan="1" colspan="1">2.86E-05</td>
                          <td align="left" rowspan="1" colspan="1">THIL_RAT,DLDH_RAT,G3V6P2_RAT,AL7A1_RAT,ECHM_RAT,DHTK1_RAT,D3ZT90_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno00380</td>
                          <td align="center" rowspan="1" colspan="1">Tryptophan metabolism</td>
                          <td align="center" rowspan="1" colspan="1">0.44</td>
                          <td align="center" rowspan="1" colspan="1">5.66</td>
                          <td align="center" rowspan="1" colspan="1">3.51E-05</td>
                          <td align="left" rowspan="1" colspan="1">THIL_RAT,DLDH_RAT,G3V6P2_RAT,AL7A1_RAT,ECHM_RAT,DHTK1_RAT,D3ZT90_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno00630</td>
                          <td align="center" rowspan="1" colspan="1">Glyoxylate and dicarboxylate metabolism</td>
                          <td align="center" rowspan="1" colspan="1">0.44</td>
                          <td align="center" rowspan="1" colspan="1">5.66</td>
                          <td align="center" rowspan="1" colspan="1">3.51E-05</td>
                          <td align="left" rowspan="1" colspan="1">ACON_RAT,MDHM_RAT,THIL_RAT,DLDH_RAT,Q68FZ8_RAT,Q5U3Z7_RAT,GCSH_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno00020</td>
                          <td align="center" rowspan="1" colspan="1">Citrate cycle (TCA cycle)</td>
                          <td align="center" rowspan="1" colspan="1">0.41</td>
                          <td align="center" rowspan="1" colspan="1">5.44</td>
                          <td align="center" rowspan="1" colspan="1">5.03E-05</td>
                          <td align="left" rowspan="1" colspan="1">ACON_RAT,MDHM_RAT,DLDH_RAT,F1LM47_RAT,IDH3B_RAT,G3V6P2_RAT,IDHP_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno00650</td>
                          <td align="center" rowspan="1" colspan="1">Butanoate metabolism</td>
                          <td align="center" rowspan="1" colspan="1">0.46</td>
                          <td align="center" rowspan="1" colspan="1">5.06</td>
                          <td align="center" rowspan="1" colspan="1">0.000107806</td>
                          <td align="left" rowspan="1" colspan="1">GABT_RAT,THIL_RAT,G3V945_RAT,SCOT1_RAT,ECHM_RAT,Q6IMX3_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno00071</td>
                          <td align="center" rowspan="1" colspan="1">Fatty acid degradation</td>
                          <td align="center" rowspan="1" colspan="1">0.32</td>
                          <td align="center" rowspan="1" colspan="1">4.57</td>
                          <td align="center" rowspan="1" colspan="1">0.000295395</td>
                          <td align="left" rowspan="1" colspan="1">THIL_RAT,AL7A1_RAT,ACADL_RAT,ECHM_RAT,D3ZT90_RAT,G3V796_RAT,Q6IMX3_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno00620</td>
                          <td align="center" rowspan="1" colspan="1">Pyruvate metabolism</td>
                          <td align="center" rowspan="1" colspan="1">0.35</td>
                          <td align="center" rowspan="1" colspan="1">4.26</td>
                          <td align="center" rowspan="1" colspan="1">0.000551788</td>
                          <td align="left" rowspan="1" colspan="1">MDHM_RAT,THIL_RAT,DLDH_RAT,F1M5N4_RAT,AL7A1_RAT,LDHA_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno00410</td>
                          <td align="center" rowspan="1" colspan="1">beta-Alanine metabolism</td>
                          <td align="center" rowspan="1" colspan="1">0.36</td>
                          <td align="center" rowspan="1" colspan="1">3.64</td>
                          <td align="center" rowspan="1" colspan="1">0.002124661</td>
                          <td align="left" rowspan="1" colspan="1">GABT_RAT,G3V7J0_RAT,AL7A1_RAT,ECHM_RAT,G3V796_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno01210</td>
                          <td align="center" rowspan="1" colspan="1">2-Oxocarboxylic acid metabolism</td>
                          <td align="center" rowspan="1" colspan="1">0.40</td>
                          <td align="center" rowspan="1" colspan="1">3.20</td>
                          <td align="center" rowspan="1" colspan="1">0.005443792</td>
                          <td align="left" rowspan="1" colspan="1">ACON_RAT,AATM_RAT,IDH3B_RAT,IDHP_RAT</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">path:rno01200</td>
                          <td align="center" rowspan="1" colspan="1">Carbon metabolism</td>
                          <td align="center" rowspan="1" colspan="1">0.33</td>
                          <td align="center" rowspan="1" colspan="1">12.58</td>
                          <td align="center" rowspan="1" colspan="1">2.92E-11</td>
                          <td align="left" rowspan="1" colspan="1">ACON_RAT,DHE3_RAT,MDHM_RAT,AATM_RAT,THIL_RAT,DLDH_RAT,F1LM47_RAT,IDH3B_RAT,G3V7J0_RAT,G3V6P2_RAT,F1M5N4_RAT,IDHP_RAT,Q68FZ8_RAT,ECHM_RAT,ENOB_RAT,Q5U3Z7_RAT,GCSH_RAT,G3V796_RAT,Q6IMX3_RAT</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <p>Next, we constructed the protein-protein interaction (PPI) network to screen for hub proteins (<bold><xref rid="pone.0265108.g003" ref-type="fig">Fig 3</xref></bold>). The top 10 high-degree hub nodes included DLD (Dihydrolipoyl dehydrogenase), CS (Citrate synthase), ACO2 (Aconitate hydratase), MDH2 (Malate dehydrogenase), DLST (Dihydrolipoamide S-succinyltransferase), IDH3A (Isocitrate dehydrogenase [NAD] subunit), ALDH6A1 (Aldehyde dehydrogenase family 6, subfamily A1, isoform CRA_b), FH (Fumarate hydratase), GLUD1 (Glutamate dehydrogenase 1), and GOT2 (Aspartate aminotransferase), and they may play an important role in mediating the effects of SM on the mitochondrial metabolic function. These data indicate that the effects of SM on mitochondria are mainly in the pathway of material metabolism and energy metabolism.</p>
                <fig position="float" id="pone.0265108.g003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0265108.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <title>The protein-protein interaction (PPI) network.</title>
                    <p>The colored nodes represented query proteins and first shell of interactors, whereas, white nodes represented second shell of interactors. Lines represented the interactions between two nodes.</p>
                  </caption>
                  <graphic xlink:href="pone.0265108.g003" position="float"/>
                </fig>
              </sec>
              <sec id="sec018">
                <title>Validation of the selected proteins in TCA by Western blotting</title>
                <p>As the tricarboxylic acid (TCA) cycle was the most enriched GO terms in the biological process category, we used Western blotting to verify the relative expressions of the 3 proteins, ACO2 DLST and CS. All of the 3 proteins were involved in TCA cycle and were the hub genes in PPI network we constructed. The mass spectrometry results showed that their mean expression levels reached 1.71 (ACO2), 1.53 (DLST), and 1.85 (CS) times that of the Control group (<bold><xref rid="pone.0265108.t001" ref-type="table">Table 1</xref></bold>). The Western blotting results showed that after 28 days of tail suspension, all three proteins were significantly upregulated, and the relative expressions of ACO2, DLST and CS reached 4.31, 2.70 and 2.70 times that of the corresponding control group, respectively (<bold><xref rid="pone.0265108.g004" ref-type="fig">Fig 4</xref></bold>). This suggests that SM greatly promotes the function of TCA cycle.</p>
                <fig position="float" id="pone.0265108.g004">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0265108.g004</object-id>
                  <label>Fig 4</label>
                  <caption>
                    <title>28-day tail suspension promotes the expression of ACO2, DLST and CS in hippocampus mitochondria of rats.</title>
                    <p><bold>(A)</bold> Protein levels of ACO2, DLST and CS were determined by immunoblotting. <bold>(B)</bold> The relative expressions of ACO2, DLST and CS were represented by the intensity ratio between the protein and the loading control (VDAC) in each lane. n = 4, error bars indicated standard deviations. *p&lt;0.05; **p&lt;0.01 compared with each control group.</p>
                  </caption>
                  <graphic xlink:href="pone.0265108.g004" position="float"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec019">
              <title>Discussion</title>
              <p>In this study, we found that 28 days of tail suspension increased the number and size of mitochondria in the hippocampus of rats and TMT-based proteomics analysis revealed 128 mitochondrial proteins upregulation and 35 mitochondrial proteins downregulation. Bioinformatics analysis implied that mitochondrial metabolic pathways related TCA cycle and fatty acid oxidation were significantly changed. We verified the upregulated expressions of three TCA cycle related proteins, ACO2, DLST and CS. Our study suggests that SM can cause mitochondrial dynamic and metabolic function related proteins changes, which may be one of the mechanisms of the effects of space microgravity on brain function.</p>
              <p>Previously, Mikheeva et al. reported that after 30 days flight on the Bion-M1 biosatellite, the number and size of mitochondria in the soma of motoneurons and in axons coming from the vestibular structures increased in mouse [<xref rid="pone.0265108.ref022" ref-type="bibr">22</xref>]. Tan et al. showed that when compared with cells maintained under normal gravity, BL6-10 cells treated with simulating microgravity showed higher mitochondrial content and more abundant cytoplasmic mitochondria, and significantly reduced glycolytic metabolism [<xref rid="pone.0265108.ref023" ref-type="bibr">23</xref>]. In consistent with these findings, our study showed that the mitochondrial number and size of rat hippocampus were increased after 28 days of tail suspension. As a highly dynamic organelle, the function of mitochondria is dynamically regulated by the fission and fusion in various cell types, thus regulating the morphology, quantity, distribution, metabolism and biogenesis of mitochondria [<xref rid="pone.0265108.ref017" ref-type="bibr">17</xref>]. Some studies indicated that mitochondrial division can enhance its function. Fulghum and Hill found that catecholamines promotes mitochondrial fission and up-regulates PGC1α, thereby dramatically increasing mitochondrial function and long-term increase in mitochondrial abundance and fatty acid oxidation capacity [<xref rid="pone.0265108.ref024" ref-type="bibr">24</xref>]. Rana et al. found that promoting mitochondrial fission in midlife Drosophila can improve multiple markers of mitochondrial function and reduce mitochondrial ROS levels [<xref rid="pone.0265108.ref025" ref-type="bibr">25</xref>]. In current study, the analysis of DEPs revealed that most of the proteins (128/163) were upregulated after tail suspension, suggesting that SM may enhance the function of mitochondria in the hippocampus possibly through influencing the fission of mitochondria, and this mechanism requires further investigation.</p>
              <p>The GO analysis of our current study showed that the most significantly enriched category in the cellular component were TCA cycle, fatty acid beta-oxidation using acyl-CoA dehydrogenase, 2-oxoglutarate metabolic process, isocitrate metabolic process and carnitine metabolic process, CoA-linked, and all of them are the important processes of mitochondria. These findings suggested that the DEPs are mainly involved in mitochondria and energy metabolism. In the TCA cycle pathway, all 13 identified proteins were upregulated. Similarly, the DEPs that involved in fatty acid beta-oxidation using acyl-CoA dehydrogenase process were also upregulated. Espinosa-Jeffrey et al. used 3D-clinostat robot to simulate the microgravity in oligodendrocytes, and found that the mitochondrial respiration and glycolysis are increased after 24 hours exposure to SM, indicating that SM enhances the mitochondrial function [<xref rid="pone.0265108.ref026" ref-type="bibr">26</xref>]. In another study, the primary osteoblasts were exposed to SM for 110 hours, and the metabonomics and proteomics results showed that TCA cycle is activated and acetyl coenzyme A is accumulated [<xref rid="pone.0265108.ref027" ref-type="bibr">27</xref>]. The real flight data also showed that microgravity increases the TCA activity. da Silveira et al. analyzed four human cell lines (fibroblasts, endothelial cells, primary T cells, and hair follicles) in vitro datasets available on GeneLab by gene set enrichment analysis (GSEA) for the overlapping pathways, and found one overlapping collection of gene sets across all four cell types, which contains four mitochondrial function gene ontology (GO) terms: mitochondrial ATP synthesis, mitochondrial electron transport, oxidative phosphorylation (OXPHOS), and hydrogen ion transmembrane transportation. They next analyzed the metabonomics data of gastrocnemius and quadriceps femoris muscles in mice after 35 days spaceflight, and the enrichment analysis showed that spaceflight increases the mitochondrial and energy metabolism related pathways, such as the b-oxidation of long-chain fatty acids and the TCA cycle [<xref rid="pone.0265108.ref014" ref-type="bibr">14</xref>]. The famous NASA twins study demonstrated that the levels of plasma TCA cycle intermediates (citric acid and malic acid) are raised during flight compared with pre-flight and post-flight levels [<xref rid="pone.0265108.ref028" ref-type="bibr">28</xref>], indicating that the TCA activity is elevated. Our results suggested that mitochondrial activity and energy metabolism are remarkably upregulated in rat hippocampus after 28-day tail suspension. Although the organizations studied are not the same, their results confirmed that our findings are similar to those in the real space microgravity environment. Material metabolism and energy metabolism are the main functions of mitochondria. The KEGG pathway analysis of our results indicated that 14 metabolic pathways showed significant differences between Control group and SM group. Almost all the material and energy metabolism, including carbon metabolism, amino acid metabolism (e.g., valine, leucine and isoleucine degradation, lysine degradation, tryptophan metabolism and beta-Alanine metabolism), TCA cycle and lipid metabolism (e.g., fatty acid degradation), have been changed significantly in our study, further proving that tail suspension can change the function of hippocampal mitochondria in rats.</p>
              <p>Protein-protein interaction (PPI) research can reveal the protein function of DEPs at the molecular level, and explain the cellular mechanism by elucidating the interaction of whole genome proteins [<xref rid="pone.0265108.ref029" ref-type="bibr">29</xref>]. In this study, we constructed the PPI network of DEPs, and found that 6 (CS, ACO2, MDH2, DLST, IDH3A and FH) of top 10 high-degree hub nodes were involved in TCA cycle. In particular, we used Western blotting to detect the expressions of ACO2, CS and DLST, and found that their expression trends were consistent with the results of proteomics. Considering that ACO2 belongs to aconitase family and plays an important role in maintaining oxidative phosphorylation and energy generation [<xref rid="pone.0265108.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0265108.ref031" ref-type="bibr">31</xref>], we believe that other nodal genes are also involved in the regulation of mitochondrial function or the downstream gene expression or metabolism by microgravity. Our proteomics analysis also showed that the expressions of antioxidant enzymes such as SOD2 and prdx3 were increased, suggesting that SM may induce the transfer of energy metabolism from glycolysis to oxidative phosphorylation in rat hippocampus. This may reflect the compensation of body to the harmful effects of SM.</p>
              <p>The future success of long-term space exploration requires a comprehensive understanding of the impact of spaceflight on human biology. After analyzing the samples from 59 astronauts and hundreds of samples flown in space by transcriptomics, proteomics, metabolomics and epigenetics, da Silveira et al. concluded that mitochondrial disorders are the central hub of space biology [<xref rid="pone.0265108.ref014" ref-type="bibr">14</xref>]. In view of the fact that true microgravity cannot be simulated on the earth, the tail suspension model only simulate the fluid shift, muscle atrophy, bone loss effects in microgravity. In our study, the effects of SM on the dynamics and proteomics of mouse hippocampal mitochondria may be the result of long-term body fluid shift. In order to ensure the health of human spaceflight, more in-depth experimental research on mitochondrial functions and molecular mechanisms are needed in the aerospace environment.</p>
            </sec>
            <sec id="sec020" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0265108.s001" position="float" content-type="local-data">
                <label>S1 Fig</label>
                <caption>
                  <title>Uncropped images of Western blots in <xref rid="pone.0265108.g004" ref-type="fig">Fig 4</xref>.</title>
                  <p>(TIF)</p>
                </caption>
                <media xlink:href="pone.0265108.s001.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0265108.s002" position="float" content-type="local-data">
                <label>S1 Table</label>
                <caption>
                  <title>Raw data of proteomics.</title>
                  <p>(XLSX)</p>
                </caption>
                <media xlink:href="pone.0265108.s002.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ref-list>
              <title>References</title>
              <ref id="pone.0265108.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Van Ombergen</surname><given-names>A</given-names></name>, <name><surname>Demertzi</surname><given-names>A</given-names></name>, <name><surname>Tomilovskaya</surname><given-names>E</given-names></name>, <name><surname>Jeurissen</surname><given-names>B</given-names></name>, <name><surname>Sijbers</surname><given-names>J</given-names></name>, <name><surname>Kozlovskaya</surname><given-names>I B</given-names></name>, <etal>et al</etal>. <article-title>The effect of spaceflight and microgravity on the human brain</article-title>. <source>J Neurol</source>. <year>2017</year>; <volume>264</volume>(<issue>Suppl 1</issue>):<fpage>18</fpage>–<lpage>22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00415-017-8427-x</pub-id>
<?supplied-pmid 28271409?><pub-id pub-id-type="pmid">28271409</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Roberts</surname><given-names>D R</given-names></name>, <name><surname>Asemani</surname><given-names>D</given-names></name>, <name><surname>Nietert</surname><given-names>P J</given-names></name>, <name><surname>Eckert</surname><given-names>M A</given-names></name>, <name><surname>Inglesby</surname><given-names>D C</given-names></name>, <name><surname>Bloomberg</surname><given-names>J J</given-names></name>, <etal>et al</etal>. <article-title>Prolonged Microgravity Affects Human Brain Structure and Function.</article-title><source>AJNR Am J Neuroradiol</source>. <year>2019</year>; <volume>40</volume>(<issue>11</issue>):<fpage>1878</fpage>–<lpage>1885</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3174/ajnr.A6249</pub-id>
<?supplied-pmid 31624117?><pub-id pub-id-type="pmid">31624117</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Song</surname><given-names>S</given-names></name>, <name><surname>Gao</surname><given-names>Z</given-names></name>, <name><surname>Lei</surname><given-names>X</given-names></name>, <name><surname>Niu</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Total Flavonoids of Drynariae Rhizoma Prevent Bone Loss Induced by Hindlimb Unloading in Rats.</article-title><source>Molecules</source>. <year>2017</year>; <volume>22</volume>(<issue>7</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/molecules22071033</pub-id><?supplied-pmid 28640230?><pub-id pub-id-type="pmid">28640230</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>D</given-names></name>, <name><surname>Zhou</surname><given-names>X</given-names></name>, <name><surname>Zheng</surname><given-names>C</given-names></name>, <name><surname>He</surname><given-names>Y</given-names></name>, <name><surname>Yu</surname><given-names>L</given-names></name>, <name><surname>Qiu</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>The effects of simulated +Gz and microgravity on intervertebral disc degeneration in rabbits.</article-title><source>Sci Rep</source>. <year>2019</year>; <volume>9</volume>(<issue>1</issue>):<fpage>16608</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-019-53246-7</pub-id><?supplied-pmid 31719640?><pub-id pub-id-type="pmid">31719640</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Q</given-names></name>, <name><surname>Dong</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>M</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>, <name><surname>Li</surname><given-names>S</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Dammarane Sapogenins Improving Simulated Weightlessness-Induced Depressive-Like Behaviors and Cognitive Dysfunction in Rats.</article-title><source>Front Psychiatry</source>. <year>2021</year>; <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fpsyt.2021.638328</pub-id> .<?supplied-pmid 33841208?><pub-id pub-id-type="pmid">33841208</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>T</given-names></name>, <name><surname>Du</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>L</given-names></name>, <name><surname>Wu</surname><given-names>Z</given-names></name>, <name><surname>Kong</surname><given-names>X</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Treatment with Minocycline Suppresses Microglia Activation and Reverses Neural Stem Cells Loss after Simulated Microgravity</article-title>. <source>Biomed Res Int</source>. <year>2020</year>; 20207348745. <comment>doi: </comment><pub-id pub-id-type="doi">10.1155/2020/7348745</pub-id><?supplied-pmid 32382569?><pub-id pub-id-type="pmid">32382569</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Nday C</surname><given-names>M</given-names></name>, <name><surname>Frantzidis</surname><given-names>C</given-names></name>, <name><surname>Jackson</surname><given-names>G</given-names></name>, <name><surname>Bamidis</surname><given-names>P</given-names></name>, <name><surname>Kourtidou-Papadeli</surname><given-names>C</given-names></name>. <article-title>Neurophysiological changes in simulated microgravity: An animal model.</article-title><source>Neurol India.</source><year>2019</year>; <volume>67</volume> (<issue>Supplement</issue>):<fpage>S221</fpage>–<lpage>S226</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4103/0028-3886.259128</pub-id>
<?supplied-pmid 31134913?><pub-id pub-id-type="pmid">31134913</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Q</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Lv</surname><given-names>K</given-names></name>, <name><surname>Wang</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Involvement of Cholinergic Dysfunction and Oxidative Damage in the Effects of Simulated Weightlessness on Learning and Memory in Rats.</article-title><source>Biomed Res Int.</source><year>2018</year>; 20182547532. <comment>doi: </comment><pub-id pub-id-type="doi">10.1155/2018/2547532</pub-id><?supplied-pmid 29581965?><pub-id pub-id-type="pmid">29581965</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>Y</given-names></name>, <name><surname>Ishibashi</surname><given-names>S</given-names></name>, <name><surname>Iglesias-Gonzalez</surname><given-names>J</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Love N</surname><given-names>R</given-names></name>, <name><surname>Amaya</surname><given-names>E</given-names></name>. <article-title>Ca(2+)-Induced Mitochondrial ROS Regulate the Early Embryonic Cell Cycle.</article-title><source>Cell Rep</source>. <year>2018</year>; <volume>22</volume>(<issue>1</issue>):<fpage>218</fpage>–<lpage>231</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.celrep.2017.12.042</pub-id>
<?supplied-pmid 29298423?><pub-id pub-id-type="pmid">29298423</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Fang</surname><given-names>Y</given-names></name>, <name><surname>Dehaen</surname><given-names>W</given-names></name>. <article-title>Fluorescent Probes for Selective Recognition of Hypobromous Acid: Achievements and Future Perspectives.</article-title><source>Molecules</source>. <year>2021</year>; <volume>26</volume>(<issue>2</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/molecules26020363</pub-id><?supplied-pmid 33445736?><pub-id pub-id-type="pmid">33445736</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Sasaki</surname><given-names>S.</given-names></name><article-title>Determination of altered mitochondria ultrastructure by electron microscopy</article-title>. <source>Methods Mol Biol</source>. <year>2010</year>; <fpage>648279</fpage>–<lpage>290</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/978-1-60761-756-3_19</pub-id>
<?supplied-pmid 20700720?><pub-id pub-id-type="pmid">20700720</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Annesley S</surname><given-names>J</given-names></name>, <name><surname>Fisher P</surname><given-names>R</given-names></name>. <article-title>Mitochondria in Health and Disease.</article-title><source>Cells</source>. <year>2019</year>; <volume>8</volume>(<issue>7</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/cells8070680</pub-id><?supplied-pmid 31284394?><pub-id pub-id-type="pmid">31284394</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Chae</surname><given-names>S</given-names></name>, <name><surname>Kim S</surname><given-names>J</given-names></name>, <name><surname>Do Koo</surname><given-names>Y</given-names></name>, <name><surname>Lee J</surname><given-names>H</given-names></name>, <name><surname>Kim</surname><given-names>H</given-names></name>, <name><surname>Ahn B</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>A mitochondrial proteome profile indicative of type 2 diabetes mellitus in skeletal muscles</article-title>. <source>Exp Mol Med</source>. <year>2018</year>; <volume>50</volume>(<issue>9</issue>):<fpage>129</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s12276-018-0154-6</pub-id><?supplied-pmid 30266947?><pub-id pub-id-type="pmid">30266947</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>da Silveira W</surname><given-names>A</given-names></name>, <name><surname>Fazelinia</surname><given-names>H</given-names></name>, <name><surname>Rosenthal S</surname><given-names>B</given-names></name>, <name><surname>Laiakis E</surname><given-names>C</given-names></name>, <name><surname>Kim M</surname><given-names>S</given-names></name>, <name><surname>Meydan</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Comprehensive Multi-omics Analysis Reveals Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact</article-title>. <source>Cell</source>. <year>2020</year>; <volume>183</volume>(<issue>5</issue>):<fpage>1185</fpage>–<lpage>1201 e1120</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2020.11.002</pub-id>
<?supplied-pmid 33242417?><pub-id pub-id-type="pmid">33242417</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Swerdlow R</surname><given-names>H.</given-names></name><article-title>Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease</article-title>. <source>J Alzheimers Dis</source>. <year>2018</year>; <volume>62</volume>(<issue>3</issue>):<fpage>1403</fpage>–<lpage>1416</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3233/JAD-170585</pub-id>
<?supplied-pmid 29036828?><pub-id pub-id-type="pmid">29036828</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Raghav</surname><given-names>L</given-names></name>, <name><surname>Chang</surname><given-names>Y H</given-names></name>, <name><surname>Hsu</surname><given-names>Y C</given-names></name>, <name><surname>Li</surname><given-names>Y C</given-names></name>, <name><surname>Chen</surname><given-names>C Y</given-names></name>, <name><surname>Yang</surname><given-names>T Y</given-names></name>, <etal>et al</etal>. <article-title>Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma.</article-title><source>Cancers (Basel).</source><year>2020</year>; <volume>12</volume>(<issue>3</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/cancers12030755</pub-id><?supplied-pmid 32210009?><pub-id pub-id-type="pmid">32210009</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>A</given-names></name>, <name><surname>Gao</surname><given-names>M</given-names></name>, <name><surname>Jiang</surname><given-names>W</given-names></name>, <name><surname>Qin</surname><given-names>Y</given-names></name>, <name><surname>Gong</surname><given-names>G</given-names></name>. <article-title>Mitochondrial Dynamics in Adult Cardiomyocytes and Heart Diseases.</article-title><source>Front Cell Dev Biol</source>. <year>2020</year>; 8584800. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fcell.2020.584800</pub-id><?supplied-pmid 33392184?><pub-id pub-id-type="pmid">33392184</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Hong</surname><given-names>C T</given-names></name>, <name><surname>Chau</surname><given-names>K Y</given-names></name>, <name><surname>Schapira</surname><given-names>A H</given-names></name>. <article-title>The Cytomegalovirus protein pUL37×1 targets mitochondria to mediate neuroprotection.</article-title><source>Sci Rep</source>. <year>2016</year>; <fpage>631373</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/srep31373</pub-id><?supplied-pmid 27562039?><pub-id pub-id-type="pmid">27562039</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Yang J</surname><given-names>L</given-names></name>, <name><surname>Mukda</surname><given-names>S</given-names></name>, <name><surname>Chen S</surname><given-names>D</given-names></name>. <article-title>Diverse roles of mitochondria in ischemic stroke</article-title>. <source>Redox Biol</source>. <year>2018</year>; <fpage>16263</fpage>–<lpage>275</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.redox.2018.03.002</pub-id>
<?supplied-pmid 29549824?><pub-id pub-id-type="pmid">29549824</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>Z</given-names></name>, <name><surname>Austin</surname><given-names>G L</given-names></name>, <name><surname>Young</surname><given-names>L E A</given-names></name>, <name><surname>Johnson L</surname><given-names>A</given-names></name>, <name><surname>Sun</surname><given-names>R</given-names></name>. <article-title>Mitochondrial Metabolism in Major Neurological Diseases.</article-title><source>Cells</source>. <year>2018</year>; <volume>7</volume>(<issue>12</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/cells7120229</pub-id><?supplied-pmid 30477120?><pub-id pub-id-type="pmid">30477120</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>T</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Lv</surname><given-names>K</given-names></name>, <name><surname>Ji</surname><given-names>G</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>iTRAQ-based proteomics analysis of hippocampus in spatial memory deficiency rats induced by simulated microgravity</article-title>. <source>J Proteomics</source>. <year>2017</year>; <fpage>16064</fpage>–<lpage>73</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jprot.2017.03.013</pub-id>
<?supplied-pmid 28341594?><pub-id pub-id-type="pmid">28341594</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Mikheeva</surname><given-names>I</given-names></name>, <name><surname>Mikhailova</surname><given-names>G</given-names></name>, <name><surname>Shtanchaev</surname><given-names>R</given-names></name>, <name><surname>Arkhipov</surname><given-names>V</given-names></name>, <name><surname>Pavlik</surname><given-names>L</given-names></name>. <article-title>Influence of a 30-day spaceflight on the structure of motoneurons of the trochlear nerve nucleus in mice</article-title>. <source>Brain research</source>. <year>2021</year>; 1758147331. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.brainres.2021.147331</pub-id><?supplied-pmid 33539796?><pub-id pub-id-type="pmid">33539796</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Tan</surname><given-names>X</given-names></name>, <name><surname>Xu</surname><given-names>A</given-names></name>, <name><surname>Zhao</surname><given-names>T</given-names></name>, <name><surname>Zhao</surname><given-names>Q</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Fan</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Simulated microgravity inhibits cell focal adhesions leading to reduced melanoma cell proliferation and metastasis via FAK/RhoA-regulated mTORC1 and AMPK pathways.</article-title><source>Scientific reports</source>. <year>2018</year>; <volume>8</volume>(<issue>1</issue>):<fpage>3769</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-018-20459-1</pub-id><?supplied-pmid 29491429?><pub-id pub-id-type="pmid">29491429</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Fulghum</surname><given-names>K</given-names></name>, <name><surname>Hill B</surname><given-names>G</given-names></name>. <article-title>Metabolic Mechanisms of Exercise-Induced Cardiac Remodeling.</article-title><source>Front Cardiovasc Med.</source><year>2018</year>; <fpage>5127</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fcvm.2018.00127</pub-id><?supplied-pmid 30255026?><pub-id pub-id-type="pmid">30255026</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Rana</surname><given-names>A</given-names></name>, <name><surname>Oliveira M</surname><given-names>P</given-names></name>, <name><surname>Khamoui A</surname><given-names>V</given-names></name>, <name><surname>Aparicio</surname><given-names>R</given-names></name>, <name><surname>Rera</surname><given-names>M</given-names></name>, <name><surname>Rossiter H</surname><given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Promoting Drp1-mediated mitochondrial fission in midlife prolongs healthy lifespan of Drosophila melanogaster.</article-title><source>Nat Commun.</source><year>2017</year>; <volume>8</volume>(<issue>1</issue>):<fpage>448</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41467-017-00525-4</pub-id><?supplied-pmid 28878259?><pub-id pub-id-type="pmid">28878259</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Espinosa-Jeffrey</surname><given-names>A</given-names></name>, <name><surname>Nguyen</surname><given-names>K</given-names></name>, <name><surname>Kumar</surname><given-names>S</given-names></name>, <name><surname>Toshimasa</surname><given-names>O</given-names></name>, <name><surname>Hirose</surname><given-names>R</given-names></name>, <name><surname>Reue</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Simulated microgravity enhances oligodendrocyte mitochondrial function and lipid metabolism</article-title>. <source>J Neurosci Res</source>. <year>2016</year>; <volume>94</volume>(<issue>12</issue>):<fpage>1434</fpage>–<lpage>1450</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/jnr.23958</pub-id>
<?supplied-pmid 27680492?><pub-id pub-id-type="pmid">27680492</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Michaletti</surname><given-names>A</given-names></name>, <name><surname>Gioia</surname><given-names>M</given-names></name>, <name><surname>Tarantino</surname><given-names>U</given-names></name>, <name><surname>Zolla</surname><given-names>L</given-names></name>. <article-title>Effects of microgravity on osteoblast mitochondria: a proteomic and metabolomics profile.</article-title><source>Sci Rep</source>. <year>2017</year>; <volume>7</volume>(<issue>1</issue>):<fpage>15376</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-017-15612-1</pub-id><?supplied-pmid 29133864?><pub-id pub-id-type="pmid">29133864</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Garrett-Bakelman F</surname><given-names>E</given-names></name>, <name><surname>Darshi</surname><given-names>M</given-names></name>, <name><surname>Green S</surname><given-names>J</given-names></name>, <name><surname>Gur R</surname><given-names>C</given-names></name>, <name><surname>Lin</surname><given-names>L</given-names></name>, <name><surname>Macias B</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight</article-title>. <source>Science</source>. <year>2019</year>; <volume>364</volume>(<issue>6436</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.aau8650</pub-id><?supplied-pmid 30975860?><pub-id pub-id-type="pmid">30975860</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Wang L</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Chen G</surname><given-names>Z</given-names></name>. <article-title>Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma.</article-title><source>PLoS One.</source><year>2018</year>; <volume>13</volume>(<issue>1</issue>):<fpage>e0190447</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0190447</pub-id><?supplied-pmid 29377892?><pub-id pub-id-type="pmid">29377892</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>C.</given-names></name><article-title>Involvement of Iron-Containing Proteins in Genome Integrity in Arabidopsis Thaliana</article-title>. <source>Genome Integr</source>. <year>2015</year>; <volume>62</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4103/2041-9414.155953</pub-id><?supplied-pmid 27330736?><pub-id pub-id-type="pmid">27330736</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0265108.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Xue Y</surname><given-names>N</given-names></name>, <name><surname>Liu Y</surname><given-names>N</given-names></name>, <name><surname>Su</surname><given-names>J</given-names></name>, <name><surname>Li J</surname><given-names>L</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Guo</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Zinc cooperates with p53 to inhibit the activity of mitochondrial aconitase through reactive oxygen species accumulation</article-title>. <source>Cancer Med</source>. <year>2019</year>; <volume>8</volume>(<issue>5</issue>):<fpage>2462</fpage>–<lpage>2473</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/cam4.2130</pub-id>
<?supplied-pmid 30972978?><pub-id pub-id-type="pmid">30972978</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
          <sub-article article-type="aggregated-review-documents" id="pone.0265108.r001" specific-use="decision-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0265108.r001</article-id>
              <title-group>
                <article-title>Decision Letter 0</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chambery</surname>
                    <given-names>Angela</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2022 Angela Chambery</copyright-statement>
                <copyright-year>2022</copyright-year>
                <copyright-holder>Angela Chambery</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0265108" id="rel-obj001" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>0</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">1 Dec 2021</named-content>
              </p>
              <p><!-- <div> -->PONE-D-21-31461<!-- </div> --><!-- <div> -->The mitochondrial proteomic changes of rat hippocampus induced by 28-day simulated microgravity<!-- </div> --><!-- <div> -->PLOS ONE</p>
              <p>Dear Dr. Ji,</p>
              <p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
              <p>Both reviewers appreciate rigor and results of your paper. However, some weaknesses and concerns were expressed by both referees mainly regarding the focus of the study and discussion of results. Since no functional analyses neither data on the morphology of mitochondria  are provided in support of proteomic data, authors are encouraged to correct the text or adequate the experimental design to support conclusions.Some experimental details should be better described in the Methods section. </p>
              <p>Please submit your revised manuscript by Jan 15 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
              <p>Please include the following items when submitting your revised manuscript:<!-- </div> --><list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list></p>
              <p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
              <p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xlink:href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link>.</p>
              <p>We look forward to receiving your revised manuscript.</p>
              <p>Kind regards,</p>
              <p>Angela Chambery, PhD</p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
              <p>Journal Requirements:</p>
              <p>When submitting your revision, we need you to address these additional requirements.</p>
              <p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at </p>
              <p><ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and </p>
              <p><ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link>.</p>
              <p>2. In your Methods section, please provide additional information on the animal research and ensure you have included details on : (1) methods of sacrifice (2) methods of anesthesia and/or analgesia, and (2) efforts to alleviate suffering.</p>
              <p>3. Thank you for stating the following in the Acknowledgments Section of your manuscript: </p>
              <p>[This work was supported by The Foundation of State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center (SMFA17A03, SMFA19B02, SMFA19K08, SMFA17B09), The National Natural Science Foundation of China (81773930, 21635001, 31800707, 31800998). The funders had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.]</p>
              <p>We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. </p>
              <p>Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: </p>
              <p> [This work was supported by The Foundation of State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center (SMFA17A03, SMFA19B02, SMFA19K08, SMFA17B09), The National Natural Science Foundation of China (81773930, 21635001, 31800707, 31800998). The funders had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.]</p>
              <p>Please include your amended statements within your cover letter; we will change the online submission form on your behalf.</p>
              <p>4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.</p>
              <p>5. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at <ext-link xlink:href="https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements" ext-link-type="uri">https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements</ext-link> and <ext-link xlink:href="https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files" ext-link-type="uri">https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files</ext-link>. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: <ext-link xlink:href="https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. " ext-link-type="uri">https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. </ext-link></p>
              <p>  </p>
              <p>In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at <email>plosone@plos.org</email> if you have any questions.</p>
              <p>Additional Editor Comments:</p>
              <p>Two expert reviewers have assessed your submission and feel that it has potential for publication, and so I would like to invite you to revise the paper.</p>
              <p>Both reviewers appreciate rigor and results of your paper. However, some weaknesses and concerns were expressed by both referees mainly regarding the focus of the study and discussion of results. Since no functional analyses neither data on morphology of mitochondria are provided in support of proteomic data, authors are encouraged to correct the text or adequate the experimental design to support conclusions. Some experimental details should be better described in the Methods section.</p>
              <p>[Note: HTML markup is below. Please do not edit.]</p>
              <p>Reviewers' comments:</p>
              <p>Reviewer's Responses to Questions</p>
              <p>
                <!-- <font color="black"> -->
                <bold>Comments to the Author</bold>
              </p>
              <p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
              <p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. <!-- </font> --></p>
              <p>Reviewer #1: Partly</p>
              <p>Reviewer #2: Partly</p>
              <p>**********</p>
              <p><!-- <font color="black"> -->2. Has the statistical analysis been performed appropriately and rigorously? <!-- </font> --></p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>**********</p>
              <p><!-- <font color="black"> -->3. Have the authors made all data underlying the findings in their manuscript fully available?</p>
              <p>The <ext-link xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.<!-- </font> --></p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>**********</p>
              <p><!-- <font color="black"> -->4. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
              <p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.<!-- </font> --></p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>**********</p>
              <p><!-- <font color="black"> -->5. Review Comments to the Author</p>
              <p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)<!-- </font> --></p>
              <p>Reviewer #1: Guohua Ji and coworkers present an original study focusing on the effects of simulated microgravity (by tail suspension for 28 days) on mitochondrial proteome in rat hippocampus.</p>
              <p>The search for mitochondrial alterations in cognitive function decline caused by the aerospace microgravity environment represents the originality of the study.</p>
              <p>The study was conducted with rigor and the results were well presented, however some weaknesses must be considered:</p>
              <p>1) The authors claim to have obtained information on mitochondrial morphology and dynamics. However no morphometric analysis were done. Morphology should be “quantitatively” described by mitochondrial size measurements, reporting data on the mitochondrial mean surface area and Feret's diameter, for example.</p>
              <p>2) The authors claim to have clearly observed in the hippocampus of T animals mitochondrial swelling, and cristae loos. This, together with an increase in mitochondrial number, lead the authors to state in favor of mitochondrial fission and altered mitochondrial dynamics. However, no data have been furnished on expression levels or activation of key markers of mitochondrial biogenesis and dynamics, such as PGC1α, mitofusins, OPA1 and DRP1.</p>
              <p>So, conclusion on mitochondrial morphology and dynamics are not at all supported by the reported data and remain speculative.</p>
              <p>3) Data obtained from the proteomic approach appear under-discussed. In particular, the observed up-regulation of key proteins of the tricarboxylic acid cycle seems to suggest a SM-induced energy shift from glycolysis to oxidative phosphorylation in the hippocampus of T rats. This, together with the observed mitochondrial ultrastructural alterations, could suggest a SM-induced mitochondrial damage. From this point of view, under-discussed is the reported up-regulation of antioxidant enzymes such as SOD2 and Peroxiredoxin 3.</p>
              <p>4) The described structural alterations which population of mitochondria concern? The synaptic mitochondria? This is not clear.</p>
              <p>5) In the manuscript test, the authors often talk about “mitochondrial function”, but no data have been furnished to conclude on respiratory properties, oxidative capacity, energy efficiency, ATP levels. They are encouraged to correct the text or adequate the experimental design to support conclusions.</p>
              <p>6) Overall, the discussion is poor and not focalized.</p>
              <p>7) As the authors themselves claim, the tail suspension model simulate fluid shift, muscle atrophy, bone loss, likely producing systemic metabolic adaptations. However, in the discussion, this aspect has been completely neglected even only as a framework for the possible effects of the model on the brain and in particular on the hippocampus.</p>
              <p>Minor:</p>
              <p>- in the text, some grammar correction is needed (Introduction: line 76, "are" is missing)</p>
              <p>Reviewer #2: In this study, the authors describe changes occurring within the mitochondrial proteome of rat hippocampus by using the tail suspension microgravity simulation model. The work is well organized, however, some concerns should be addressed by the authors.</p>
              <p>Minor revisions</p>
              <p>Materials and methods section</p>
              <p>- Please, detail the “Processing” and “Consensus” workflow nodes used for the raw data processing via Proteome Discoverer.</p>
              <p>- Information on the chromatographic gradient used for LC-MS/MS analyses together with tags used for labelling are missing. Please, specify.</p>
              <p>- Does the Uniprot_Rat database include TrEMBL entries? Please, specify by including the version of the UniProt release.</p>
              <p>Results section</p>
              <p>- In Table 1 and Table 3, please include the Accession Code of the identified proteins.</p>
              <p>- In the PPI network, mark with a different colour additional interactors, besides DE identified proteins, if included.</p>
              <p>Major revisions</p>
              <p>Materials and methods section</p>
              <p>The accurate sample quantification is a prerequisite for TMT labelling. Sample up- or under-estimation could tremendously affect the result of the analyses in terms of protein modulation. BCA assay is strongly recommended by ThermoFisher as detailed in the TMT datasheet. Since that it is not specified in the manuscript, did you perform it for samples quantification?</p>
              <p>Discussion</p>
              <p>The discussion of proteomic data is very poor. Moreover, besides indicating the pathways affected by changes in protein expression, the authors don’t provide data concerning neither the function nor the morphology of mitochondria.</p>
              <p>Please, better focus the proteomic data discussion. In addition, attenuate the sentences concerning functional analyses if any additional experimental data are provided.</p>
              <p>**********</p>
              <p><!-- <font color="black"> -->6. PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
              <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
              <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.<!-- </font> --></p>
              <p>Reviewer #1: <bold>Yes: </bold>Elena Silvestri</p>
              <p>Reviewer #2: No</p>
              <p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
              <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
            </body>
          </sub-article>
          <sub-article article-type="author-comment" id="pone.0265108.r002">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0265108.r002</article-id>
              <title-group>
                <article-title>Author response to Decision Letter 0</article-title>
              </title-group>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0265108" id="rel-obj002" related-article-type="editor-report"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>1</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="author-response-date">14 Jan 2022</named-content>
              </p>
              <p>Journal Requirements:</p>
              <p>When submitting your revision, we need you to address these additional requirements.</p>
              <p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at </p>
              <p><ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and </p>
              <p><ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link>.</p>
              <p>Reply: We confirmed that our manuscript meets PLOS ONE's style requirements.</p>
              <p>2. In your Methods section, please provide additional information on the animal research and ensure you have included details on : (1) methods of sacrifice (2) methods of anesthesia and/or analgesia, and (2) efforts to alleviate suffering.</p>
              <p>Reply: Information on (1) methods of sacrifice, (2) methods of anesthesia and/or analgesia, (3) efforts to alleviate suffering were added to the “Animals and SM model construction” and “Transmission electron microscopy” sections in the Material and Methods section.</p>
              <p>3. Thank you for stating the following in the Acknowledgments Section of your manuscript: </p>
              <p>[This work was supported by The Foundation of State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center (SMFA17A03, SMFA19B02, SMFA19K08, SMFA17B09), The National Natural Science Foundation of China (81773930, 21635001, 31800707, 31800998). The funders had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.]</p>
              <p>We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. </p>
              <p>Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: </p>
              <p> [This work was supported by The Foundation of State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center (SMFA17A03, SMFA19B02, SMFA19K08, SMFA17B09), The National Natural Science Foundation of China (81773930, 21635001, 31800707, 31800998). The funders had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.]</p>
              <p>Please include your amended statements within your cover letter; we will change the online submission form on your behalf.</p>
              <p>Reply: Thanks for reminding. We have deleted the Acknowledgments section and the funding information in the manuscript and include the amended statements in the cover letter.</p>
              <p>4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.</p>
              <p>Reply: We have uploaded the original proteomic data as an attachment named S1_Raw_data. So the Data Availability statement can be changed to “All relevant data are within the manuscript and its Supporting Information files”.</p>
              <p>5. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at <ext-link xlink:href="https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements" ext-link-type="uri">https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements</ext-link> and <ext-link xlink:href="https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files" ext-link-type="uri">https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files</ext-link>. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: <ext-link xlink:href="https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels" ext-link-type="uri">https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels</ext-link>. </p>
              <p>In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at <email>plosone@plos.org</email> if you have any questions.</p>
              <p>Response: We have provided the original underlying images for Figure 4 in our manuscript with the name of S2_raw_images.</p>
              <p>Additional Editor Comments:</p>
              <p>Two expert reviewers have assessed your submission and feel that it has potential for publication, and so I would like to invite you to revise the paper.</p>
              <p>Both reviewers appreciate rigor and results of your paper. However, some weaknesses and concerns were expressed by both referees mainly regarding the focus of the study and discussion of results. Since no functional analyses neither data on morphology of mitochondria are provided in support of proteomic data, authors are encouraged to correct the text or adequate the experimental design to support conclusions. Some experimental details should be better described in the Methods section.</p>
              <p>Reply: Thank you. In order to make the article more rigorous, we have revised the discussion section to make it more focused; mitochondrial area and diameter were analyzed to support proteomic data; Part of the text has been corrected to support the conclusion; some experimental details are better described. Please refer to the revised manuscript for details.</p>
              <p>Reviewers' comments:</p>
              <p>Reviewer's Responses to Questions</p>
              <p>Comments to the Author</p>
              <p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
              <p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.</p>
              <p>Reviewer #1: Partly</p>
              <p>Reviewer #2: Partly</p>
              <p>2. Has the statistical analysis been performed appropriately and rigorously?</p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p>
              <p>The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
              <p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>5. Review Comments to the Author</p>
              <p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
              <p>Reviewer #1: Guohua Ji and coworkers present an original study focusing on the effects of simulated microgravity (by tail suspension for 28 days) on mitochondrial proteome in rat hippocampus.</p>
              <p>The search for mitochondrial alterations in cognitive function decline caused by the aerospace microgravity environment represents the originality of the study.</p>
              <p>The study was conducted with rigor and the results were well presented, however some weaknesses must be considered:</p>
              <p>1) The authors claim to have obtained information on mitochondrial morphology and dynamics. However no morphometric analysis were done. Morphology should be “quantitatively” described by mitochondrial size measurements, reporting data on the mitochondrial mean surface area and Feret's diameter, for example.</p>
              <p>Reply: Thank you for your suggestion. We analyzed the original picture of transmission electron microscope, and attached the results of the average surface area and Feret's diameter of mitochondria in the manuscript.</p>
              <p>2) The authors claim to have clearly observed in the hippocampus of T animals mitochondrial swelling, and cristae loos. This, together with an increase in mitochondrial number, lead the authors to state in favor of mitochondrial fission and altered mitochondrial dynamics. However, no data have been furnished on expression levels or activation of key markers of mitochondrial biogenesis and dynamics, such as PGC1α, mitofusins, OPA1 and DRP1.</p>
              <p>So, conclusion on mitochondrial morphology and dynamics are not at all supported by the reported data and remain speculative.</p>
              <p>Reply: Thank you for your comments. We changed the word "fission" in the abstract and discussion section to "number" to make our conclusion more rigorous.</p>
              <p>3) Data obtained from the proteomic approach appear under-discussed. In particular, the observed up-regulation of key proteins of the tricarboxylic acid cycle seems to suggest a SM-induced energy shift from glycolysis to oxidative phosphorylation in the hippocampus of T rats. This, together with the observed mitochondrial ultrastructural alterations, could suggest a SM-induced mitochondrial damage. From this point of view, under-discussed is the reported up-regulation of antioxidant enzymes such as SOD2 and Peroxiredoxin 3.</p>
              <p>Reply: Thank you for your wonderful comments. We agree with you on energy shift and mitochondrial damage induced by SM, and modified the discussion part of the manuscript. Please refer to it. Although the ultrastructural changes of mitochondria and the up regulation of antioxidant enzymes such as SOD2 and peroxidase 3 were observed, there was no evidence that mitochondria were damaged. On the contrary, our results showed that the expression of metabolism related proteins were up-regulated, such as TCA cycle related enzymes, so we believe that tail suspension caused the up regulation of mitochondrial function.</p>
              <p>4) The described structural alterations which population of mitochondria concern? The synaptic mitochondria? This is not clear.</p>
              <p>Reply: The morphological changes of mitochondria come from the neuronal soma. We have changed the relevant expression in the manuscript to make it clearer. </p>
              <p>5) In the manuscript test, the authors often talk about “mitochondrial function”, but no data have been furnished to conclude on respiratory properties, oxidative capacity, energy efficiency, ATP levels. They are encouraged to correct the text or adequate the experimental design to support conclusions.</p>
              <p>Reply: In order to make our conclusion more rigorous, we have changed the word “mitochondrial function” in line 305 to “mitochondrial metabolic function”, the “mitochondrial function” in line 344 to “function related proteins”, and the “function of mitochondria” in line 367 to “morphology of mitochondria” in the revised manuscript.</p>
              <p>6) Overall, the discussion is poor and not focalized.</p>
              <p>Reply: We have revised the discussion part of the manuscript according to the comments of the reviewers, and hope to meet your requirements.</p>
              <p>7) As the authors themselves claim, the tail suspension model simulate fluid shift, muscle atrophy, bone loss, likely producing systemic metabolic adaptations. However, in the discussion, this aspect has been completely neglected even only as a framework for the possible effects of the model on the brain and in particular on the hippocampus.</p>
              <p>Reply: In the discussion part, we explain the possible causes of the phenomena observed in this study.</p>
              <p>Minor:</p>
              <p>- in the text, some grammar correction is needed (Introduction: line 76, "are" is missing)</p>
              <p>Reply: Thank you. We have corrected this mistake.</p>
              <p>Reviewer #2: In this study, the authors describe changes occurring within the mitochondrial proteome of rat hippocampus by using the tail suspension microgravity simulation model. The work is well organized, however, some concerns should be addressed by the authors.</p>
              <p>Minor revisions</p>
              <p>Materials and methods section</p>
              <p>- Please, detail the “Processing” and “Consensus” workflow nodes used for the raw data processing via Proteome Discoverer.</p>
              <p>- Information on the chromatographic gradient used for LC-MS/MS analyses together with tags used for labelling are missing. Please, specify.</p>
              <p>- Does the Uniprot_Rat database include TrEMBL entries? Please, specify by including the version of the UniProt release.</p>
              <p>Reply: Thank you. We have described these methods in detail. Please refer to the TMT- based proteomics analysis section of the revised materials and methods.</p>
              <p>Results section</p>
              <p>- In Table 1 and Table 3, please include the Accession Code of the identified proteins.</p>
              <p>- In the PPI network, mark with a different colour additional interactors, besides DE identified proteins, if included.</p>
              <p>Reply: We have added Accession Code of the identified proteins to Table1 and Table 3. In addition to the DE identified protein, there is another protein involved in the second shell of interactors, which we have shown in the PPI network diagram with white colour.</p>
              <p>Major revisions</p>
              <p>Materials and methods section</p>
              <p>The accurate sample quantification is a prerequisite for TMT labelling. Sample up- or under-estimation could tremendously affect the result of the analyses in terms of protein modulation. BCA assay is strongly recommended by ThermoFisher as detailed in the TMT datasheet. Since that it is not specified in the manuscript, did you perform it for samples quantification?</p>
              <p>Reply: Thank you. The protein concentration was quantified by BCA assay and described in the method section of the revised manuscript.</p>
              <p>Discussion</p>
              <p>The discussion of proteomic data is very poor. Moreover, besides indicating the pathways affected by changes in protein expression, the authors don’t provide data concerning neither the function nor the morphology of mitochondria.</p>
              <p>Please, better focus the proteomic data discussion. In addition, attenuate the sentences concerning functional analyses if any additional experimental data are provided.</p>
              <p>Reply: Thank you for your comments. We supplemented the data of mitochondrial morphological analysis in the revised manuscript, and changed the word “mitochondrial function” to “mitochondrial number” in appropriate places; The discussion part has been improved to focus more on proteomic data.</p>
              <p>6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.</p>
              <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
              <p>Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.</p>
              <p>Reviewer #1: Yes: Elena Silvestri</p>
              <p>Reviewer #2: No</p>
              <p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
              <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
              <p>In compliance with data protection regulations, you may request that we remove your personal registration details at any time. (Remove my information/details). Please contact the publication office if you have any questions.</p>
              <supplementary-material id="pone.0265108.s003" position="float" content-type="local-data">
                <label>Attachment</label>
                <caption>
                  <p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers.docx</named-content></p>
                </caption>
                <media xlink:href="pone.0265108.s003.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </body>
          </sub-article>
          <sub-article article-type="aggregated-review-documents" id="pone.0265108.r003" specific-use="decision-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0265108.r003</article-id>
              <title-group>
                <article-title>Decision Letter 1</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chambery</surname>
                    <given-names>Angela</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2022 Angela Chambery</copyright-statement>
                <copyright-year>2022</copyright-year>
                <copyright-holder>Angela Chambery</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0265108" id="rel-obj003" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>1</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">27 Jan 2022</named-content>
              </p>
              <p><!-- <div> -->PONE-D-21-31461R1<!-- </div> --><!-- <div> -->The mitochondrial proteomic changes of rat hippocampus induced by 28-day simulated microgravity<!-- </div> --><!-- <div> -->PLOS ONE</p>
              <p>Dear Dr. Ji,</p>
              <p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
              <p>Expert reviewers have assessed your revised submission and feel that the paper has been greatly improved in terms of clarity of exposure, organization and responses to previous concerns.</p>
              <p>Nevertheless, before acceptance, there are still few minor points that needs to be addressed regarding some typos or English grammar errors. We would like to invite you to carefully reread the text and correct any errors.</p>
              <p>Please submit your revised manuscript by Mar 13 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <email>plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
              <p>Please include the following items when submitting your revised manuscript:<!-- </div> --><list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list><!-- <div> -->If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
              <p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xlink:href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link>.</p>
              <p>We look forward to receiving your revised manuscript.</p>
              <p>Kind regards,</p>
              <p>Angela Chambery, PhD</p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
              <p>Journal Requirements:</p>
              <p>Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
              <p>Additional Editor Comments (if provided):</p>
              <p>Expert reviewers have assessed your revised submission and feel that the paper has been greatly improved in terms of clarity of exposure, organization and responses to previous concerns.</p>
              <p>Nevertheless, before acceptance, there are still few minor points that needs to be addressed regarding some typos or English grammar errors. We would like to invite you to carefully reread the text and correct any errors.</p>
              <p>[Note: HTML markup is below. Please do not edit.]</p>
              <p>Reviewers' comments:</p>
              <p>Reviewer's Responses to Questions</p>
              <p>
                <!-- <font color="black"> -->
                <bold>Comments to the Author</bold>
              </p>
              <p>1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.<!-- </font> --></p>
              <p>Reviewer #1: All comments have been addressed</p>
              <p>Reviewer #2: All comments have been addressed</p>
              <p>**********</p>
              <p><!-- <font color="black"> -->2. Is the manuscript technically sound, and do the data support the conclusions?</p>
              <p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. <!-- </font> --></p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>**********</p>
              <p><!-- <font color="black"> -->3. Has the statistical analysis been performed appropriately and rigorously? <!-- </font> --></p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: N/A</p>
              <p>**********</p>
              <p><!-- <font color="black"> -->4. Have the authors made all data underlying the findings in their manuscript fully available?</p>
              <p>The <ext-link xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.<!-- </font> --></p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>**********</p>
              <p><!-- <font color="black"> -->5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
              <p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.<!-- </font> --></p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>**********</p>
              <p><!-- <font color="black"> -->6. Review Comments to the Author</p>
              <p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)<!-- </font> --></p>
              <p>Reviewer #1: The authors answered the asked questions and accordingly modified the manuscript.</p>
              <p>However, the text still contains some typos or English grammar errors.</p>
              <p>Authors should carefully reread the text and correct any errors.</p>
              <p>Reviewer #2: (No Response)</p>
              <p>**********</p>
              <p><!-- <font color="black"> -->7. PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
              <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
              <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.<!-- </font> --></p>
              <p>Reviewer #1: No</p>
              <p>Reviewer #2: No</p>
              <p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
              <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.<!-- </div> --></p>
            </body>
          </sub-article>
          <sub-article article-type="author-comment" id="pone.0265108.r004">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0265108.r004</article-id>
              <title-group>
                <article-title>Author response to Decision Letter 1</article-title>
              </title-group>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0265108" id="rel-obj004" related-article-type="editor-report"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>2</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="author-response-date">10 Feb 2022</named-content>
              </p>
              <p>Journal Requirements:</p>
              <p>Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
              <p>Reply: We carefully checked the literatures cited in the revised manuscript, and found no retracted paper in the cited literatures.</p>
              <p>Additional Editor Comments (if provided):</p>
              <p>Expert reviewers have assessed your revised submission and feel that the paper has been greatly improved in terms of clarity of exposure, organization and responses to previous concerns.</p>
              <p>Nevertheless, before acceptance, there are still few minor points that needs to be addressed regarding some typos or English grammar errors. We would like to invite you to carefully reread the text and correct any errors.</p>
              <p>Reply: Thanks. We have revised the artical carefully and corrected the typos or English grammar errors. Please refer to the revised manuscript.</p>
              <p>[Note: HTML markup is below. Please do not edit.]</p>
              <p>Reviewers' comments:</p>
              <p>Reviewer's Responses to Questions</p>
              <p>Comments to the Author</p>
              <p>1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.</p>
              <p>Reviewer #1: All comments have been addressed</p>
              <p>Reviewer #2: All comments have been addressed</p>
              <p>2. Is the manuscript technically sound, and do the data support the conclusions?</p>
              <p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.</p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>3. Has the statistical analysis been performed appropriately and rigorously?</p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: N/A</p>
              <p>4. Have the authors made all data underlying the findings in their manuscript fully available?</p>
              <p>The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.</p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
              <p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p>
              <p>Reviewer #1: Yes</p>
              <p>Reviewer #2: Yes</p>
              <p>6. Review Comments to the Author</p>
              <p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p>
              <p>Reviewer #1: The authors answered the asked questions and accordingly modified the manuscript.</p>
              <p>However, the text still contains some typos or English grammar errors.</p>
              <p>Authors should carefully reread the text and correct any errors.</p>
              <p>Reviewer #2: (No Response)</p>
              <p>Reply: Thank you for your attention to spelling and grammatical errors in the article. We have revised the artical carefully and corrected the typos or English grammar errors. Please refer to the revised manuscript.</p>
              <p>7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.</p>
              <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
              <p>Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.</p>
              <p>Reviewer #1: No</p>
              <p>Reviewer #2: No</p>
              <p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
              <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
              <p>Reply: Thanks. The uploaded pictures have been adjusted by PACE.</p>
              <supplementary-material id="pone.0265108.s004" position="float" content-type="local-data">
                <label>Attachment</label>
                <caption>
                  <p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers.docx</named-content></p>
                </caption>
                <media xlink:href="pone.0265108.s004.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </body>
          </sub-article>
          <sub-article article-type="editor-report" id="pone.0265108.r005" specific-use="decision-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0265108.r005</article-id>
              <title-group>
                <article-title>Decision Letter 2</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chambery</surname>
                    <given-names>Angela</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2022 Angela Chambery</copyright-statement>
                <copyright-year>2022</copyright-year>
                <copyright-holder>Angela Chambery</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0265108" id="rel-obj005" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>2</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">24 Feb 2022</named-content>
              </p>
              <p>The mitochondrial proteomic changes of rat hippocampus induced by 28-day simulated microgravity</p>
              <p>PONE-D-21-31461R2</p>
              <p>Dear Dr. Ji,</p>
              <p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
              <p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
              <p>An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <ext-link xlink:href="http://www.editorialmanager.com/pone/" ext-link-type="uri">http://www.editorialmanager.com/pone/</ext-link>, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <email>authorbilling@plos.org</email>.</p>
              <p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p>
              <p>Kind regards,</p>
              <p>Angela Chambery, PhD</p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
              <p>Additional Editor Comments (optional):</p>
              <p>Reviewers' comments:</p>
            </body>
          </sub-article>
          <sub-article article-type="editor-report" id="pone.0265108.r006" specific-use="acceptance-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0265108.r006</article-id>
              <title-group>
                <article-title>Acceptance letter</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chambery</surname>
                    <given-names>Angela</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2022 Angela Chambery</copyright-statement>
                <copyright-year>2022</copyright-year>
                <copyright-holder>Angela Chambery</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0265108" id="rel-obj006" related-article-type="reviewed-article"/>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">1 Mar 2022</named-content>
              </p>
              <p>PONE-D-21-31461R2 </p>
              <p>The mitochondrial proteomic changes of rat hippocampus induced by 28-day simulated microgravity </p>
              <p>Dear Dr. Ji:</p>
              <p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. </p>
              <p>If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <email>onepress@plos.org</email>.</p>
              <p>If we can help with anything else, please email us at <email>plosone@plos.org</email>. </p>
              <p>Thank you for submitting your work to PLOS ONE and supporting open access. </p>
              <p>Kind regards, </p>
              <p>PLOS ONE Editorial Office Staff</p>
              <p>on behalf of</p>
              <p>Dr. Angela Chambery </p>
              <p>Academic Editor</p>
              <p>PLOS ONE</p>
            </body>
          </sub-article>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
